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ABSTRACT

Measuring Growth: The Reliability and Validity of the Utah Recovery Scale

R. Jason Katzenbach
Department of Counseling Psychology & Special Education, BYU
Doctor of Philosophy
Recently the direction of consumer mental health care in the United States has shifted in
terms of its approach to recovery. In this sense recovery is not thought to be a complete
amelioration of symptoms, but rather the acquisition of meaningful relationships, independent
living, and fulfilling work. In response to these changes, the Utah division of the National
Alliance for the Mentally Ill (NAMI-Utah) conducted consumer focus groups for the purpose of
developing a tool to monitor this new conceptualization of recovery. The focus groups generated
10 recovery indicators based on recovery as the Substance Abuse and Mental Health Services
Administration have defined it. This study explored initial psychometric reliability and validity
estimates for these recovery indicators and their ability to track changes in recovery over time.
In addition, the study also explored the relationship between distress reduction and recovery both
concurrently and over time.
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Introduction
In 2005, the Substance Abuse and Mental Health Services Administration (SAMHSA)
introduced their federal action agenda to change the system of mental health care delivery in the
United States. The agenda includes several strategies for improving mental health services in the
United States, such as implementing evidence-based practices, focusing on recovery, and making
treatment consumer/family driven (SAMHSA, 2005). Central to SAMHSA’s strategies is the
idea that recovery from mental illness is not merely possible, but is rather the expected outcome
of effective mental health treatment. This understanding of recovery shows how the definition of
recovery has evolved (Jacobson, 2004).
Historically, recovery was thought to be a total amelioration of all psychiatric symptoms.
Recovery, according to this definition, was defined by consumer’s returning to a pre-morbid
state of functioning. In other words, consumers were thought to have recovered when they
return to a state of functioning equal to their prior functioning before the onset of any
psychopathological symptoms (Davidson, O'Connell, Tondora, Lawless, & Evans, 2005). In this
sense, the care provider determines recovery without consumer input.
More recently, however, a new definition of recovery has emerged which focuses on the
ability of consumers of mental health services to live independently and function as contributing
members in society (Jacobson, 2004). Much of the recent recovery literature has shifted towards
this newer approach to recovery, which asserts that a total absence of psychopathology is
unlikely to be achieved but that recovery happens when the mental health consumer is able to
function normally in society through obtaining meaningful work, fulfilling relationships and
independent living (Davidson, et al., 2005; Jacobson, 2004). Recovery in this sense also
involves acquiring positive coping skills, restoring a sense of self, and pursuing purposeful living
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(O'Connor & Delaney, 2007). It does not require a return to pre-morbid functioning; instead,
mental illness is viewed as a manageable part of an otherwise complete person (Davidson et al.,
2005). This definition of recovery allows for a wide range of variability as to when recovery is
actually achieved. Some view it as being achieved when consumers of mental health services are
able to live independently and find meaningful work, while others view it as an ongoing life-long
process (Jacobson, 2004). Recovery is also considered to be an individual and subjective
experience, meaning that it is difficult to define in specific terms (Jacobson & Greenley, 2001).
The achievement of recovery in this sense is not determined merely by the care provider as it is
in the previous definition of recovery, but rather, by a joint effort between the consumer, the care
provider, and the consumer’s family (Frese, Stanley, Kress, & Vogel-Scibilia, 2001; Jacobson,
2004).
SAMHSA’s previously mentioned federal action agenda favors this newer approach to
recovery: that recovery is a continuous process defined by independent living, meaningful work,
and fulfilling relationships (SAMHSA, 2005). In order to more clearly define the construct of
recovery as it pertains to the mental health community in the Unites States, SAMHSA organized
a panel of mental health consumers, family members, providers, advocates, researchers,
academicians, managed care representatives, and accreditation organization representatives
which together compiled a consensus definition of recovery. The resulting consensus statement
comprised 10 components that define recovery: Self-Direction, Individualized and PersonCentered, Empowerment, Holistic, Non-Linear, Strengths-Based, Peer Support, Respect,
Responsibility, and Hope (SAMHSA, 2006) (see Appendix A). SAMHSA’s components are
purposely non-specific in order to allow for a wide range of individual recovery. They do,
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however, specify a direction for mental health service providers to steer towards in terms of
recovery.
In an effort to conform their mental health services to SAMHSA’s 10 fundamental
recovery components, the Utah division of the National Alliance on Mental Illness (NAMI-Utah)
conducted focus groups of consumers in order to develop questions that could assess recovery
based on both SAMHSA’s model and consumer input. The focus groups operationalized the 10
components and developed 10 questions to serve as recovery indicators. The resulting 10
indicators, labeled the Utah Recovery Scale (URS), provide practitioners with a means of
measuring recovery derived both from theory and consumer opinion (see Appendix A).
The recovery movement has garnered a large amount of consumer support and has begun
to affect policy in the mental health treatment community. Despite the ability of this movement
to effect change, very little testing as to whether the implementation of this new recovery
paradigm is actually beneficial for consumers has been done. Furthermore, the research that has
been done has typically relied strictly on the input of a few consumers in order to shape how
recovery is measured, rather than incorporating a clear definition of the construct of recovery
into their measure creation.
In addition, the existing research on recovery has also lacked theoretical and empirical
grounding in terms of how the results are interpreted. Many of the components of the recovery
model are not new and have been researched in other areas, such as positive psychology. In
order for a recovery measure to be valid and clinically useful it must be based on a clear
definition of recovery as well as consumer input. It must also be placed in a context of existing
empirical research. Such a measure should be able to track changes in recovery over time so as
to be beneficial for practitioners attempting to implement the recovery model.
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This study is a psychometric examination of the URS which seeks to solve some of these
proposed problems by comparing the URS, which was developed using both a clarified construct
of recovery and consumer input, with a gold standard measure of psychotherapeutic outcome.
Doing so will allow us to investigate both the psychometric utility of this new recovery
instrument and the relationship between a traditional model of recovery based on symptom
amelioration and this newer conceptualization of recovery. Further, this study will look to
existing empirical research in the related area of positive psychology in order to provide a
context in which to interpret the results of the study.
Literature Review
This section will review the construct of recovery, recovery measures, a possible
empirical context for recovery—positive psychology, and measurement theory.
Recovery
Recovery has always been the central concept of psychiatric rehabilitation (O'Connor &
Delaney, 2007). However, it has meant different things at different times within the mental
health care community (Davidson & Roe, 2007). The first, and more traditional, meaning
referred to symptom amelioration and the reduction of distress in those suffering from mental
illness (Davidson, Lawless, & Leary, 2005; Davidson & Roe, 2007; N. Jacobson, 2004). In other
words, recovery was thought to have occurred based on the absence of mental illness and
symptomatic distress. More recently, however, a movement has arisen within the mental health
community that endorses a definition of recovery based on an individual’s ability to live a
fulfilling and meaningful life with a mental illness (Davidson, et al., 2005; Davidson & Roe,
2007; Jacobson, 2004; Jacobson & Greenley, 2001). According to this definition, recovery is not
dependent on symptom amelioration but rather an individual’s ability to live a full and
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meaningful life while coping with illness. This paradigm of recovery posits that individuals
suffering from severe mental illness can live meaningful lives in an environment of their own
choosing (O'Connor & Delaney, 2007).
According to this newer definition of recovery, an individual’s acceptance of the mental
illness is seen as helpful in the recovery process. Roe & Kravetz (2003) compared mental illness
to a physical disability, such as paraplegia, with which an individual can learn to live a full and
meaningful life. In other words, in order for a person suffering from mental illness to live a full
and meaningful life they would need to make a number of adaptations to their daily living habits,
much like how paraplegics would have to adapt their life style to their condition. In order for an
individual to engage in this adaptation process, however, they must first accept their mental
illness much as a person that has lost the use of their legs must accept their condition in order to
move forward with their lives. Such an approach to recovery may not be ideal in the sense that
the consumer experiences a complete absence of symptoms; however, it allows an individual to
return to a somewhat normal and meaningful life (Davidson & Roe, 2007).
The fundamental aspects of recovery from this perspective are thought to relate to distress
but exist on a separate continuum in the sense that an individual can grow, live meaningfully and
purposefully while not living completely symptom free. In other words, mental illness is thought
to be just a part of a whole person rather than the defining aspect of that individual (Davidson et
al., 2005). This approach to recovery has also been described as overcoming the stigma of being
a “mental patient” such as poor housing, isolation, unemployment, loss of social roles, loss of
purpose in life, and iatrogenic consequences of involuntary treatment and hospitalization. It
allows patients to regain some control over their lives (Davidson, et al., 2005). According to
Jacobson and Curtis (2000), recovery is achieved when individuals can reclaim their own lives,
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becoming autonomous individuals, competent and able to have control over their own lives. In
addition, the recovery paradigm allows for consumer inclusion in services, thereby providing for
a collaborative effort in facilitating recovery (Jacobson & Curtis, 2000).
This recovery model for treating mental illness has been a relatively recent development
within the mental health services community and has arisen largely in response to lobbies from
consumer advocacy groups such as the National Alliance for the Mentally Ill (NAMI) (Davidson
et al., 2005; Davidson & Roe, 2007; Jacobson, 2004). For this reason, this new definition of
recovery is thought to be more consumer-centric, as opposed to disorder centric (Frese et al.,
2001). In other words, this approach to recovery focuses on the consumer as a whole, by
focusing on the consumer’s quality of life instead of just their symptoms. In addition, this
approach is also consumer centric in that treatment is defined by the hopes and desires of the
consumer as opposed to top down decisions from the health care providers. According to Frese,
the recovery model emphasizes the idea that responsibility for and control of the recovery
process belongs mostly to the consumer. According to Jacobson and Curtis (2000), that
responsibility is not only part of the recovery process, but essential to it. This approach, which
brings consumers to the table when changes to treatment are being considered, may also go a
long way toward letting consumers feel that their contributions are valued and that the decision
making process is fair (Frese et al., 2001).
Many researchers and practitioners have questioned the utility of the new recovery model
because its components were not derived from existing theory or empirical research (Davidson,
O'Connell, Tondora, Styron, & Kangas, 2006; Fisher & Ahern, 2002; Peyser, 2001; Peyser,
2001). These questions have been raised largely to call into question the ethics and economics of
implementing programs based on the recovery model. Regardless of the fact that the recovery
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model has arisen from consumers who feel the approaches proposed in the recovery model are
missing in their treatment, there are those practitioners who do not want to spend money on new
programs which are unproven in efficacy and may distract from interventions which are already
shown to improve outcome.
The recovery model’s political origin has made studying recovery challenging because this
new approach to recovery has been operationalized and defined in a number of different ways.
Further, no theoretical or empirical context has, to this point, been utilized in order to
contextualize and interpret the results from recovery measures. Because of this ambiguity,
recovery has been defined and measured in a myriad of different ways (e.g., in a compendium of
recovery measures put together by The Evaluation Center at the Human Services Research
Institute, over 42 different domains were measured in association with recovery) (CampbellOrde, Chamberlin, Carpernter, & Leff, 2005). This wide range of domains involved in studying
recovery illustrates the lack of consensus in defining recovery as a construct.
In response to the ambiguity described above, SAMHSA organized a two day conference
in which 110 expert panelists consisting of mental health consumers, family members, providers,
advocates, researchers, academicians, managed-care representatives, and accreditation
organization representatives reviewed and discussed the recovery literature and created a 10-part
consensus statement defining the fundamental components of recovery (see Appendix E)
(SAMHSA, 2006). SAMHSA’s resulting consensus statement on recovery provides researchers
and clinicians with a more concise description of the recovery model. Further, this definition
clarifies the recovery model as a construct that may lead to the development of recovery
measures of greater utility for mental health service providers. SAMHSA’s consensus statement
on recovery organizes the recovery model into 10 fundamental components (see Appendix E).
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These components, while useful, do not provide the recovery model with a bridge to existing
psychological theory or empirical research. In other words, SAMHSA’s definition still lacks a
comprehensive theoretical and empirical base and could be thought of as a consensus statement
representing a compromise among groups pushing for change. In order to address this problem,
this study will utilize an empirical context of positive psychology in order to contextualize the
results of the recovery measure in question. Positive psychology has been identified as a
possible empirical bridge for the recovery model and provides a wide range of evidence for the
types of well-being style interventions described in SAMHSA’s recovery components (Resnick
& Rosenheck, 2006).
In addition to an established context, the recovery model needs to be tested. Doing so will
allow the model to be investigated and improved to further benefit consumers. There has been
some debate, however, as to whether recovery should be measured, and what risks are involved
in doing so (Jacobson & Curtis, 2000). The evidence-based model has been perceived by some
in the recovery movement as stamping out hope by emphasizing an external locus of control
(Frese et al., 2001). Building an evidence base for recovery, however, need not necessarily
promote an external locus of control; instead, testing the model will allow it to gain more
credibility and will serve to quiet many of the recovery model’s critics who have complained
about the models lack of empirical support. In addition, an evidence-based approach has the
potential not only to provide support for the recovery model but also may serve to further refine
the model to benefit consumers (O’Connor & Delaney, 2007). One of the purposes of this study
is to begin to initiate such an endeavor by seeking to validate a potential measure of recovery.
According to Frese et al. (2001), the question of whether evidence-based practices can
co-exist with the recovery model is an essential question to answer. They suggest that in order
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for evidence-based practice to gain the support and advocacy of consumers that it is important
for evidence-based practices to incorporate aspects of the recovery movement. They also
suggest that researchers should be exploring ways for evidence-based practices to incorporate the
subjective philosophical push of the recovery movement. One area in which the recovery model
could be used is as an outcome criterion. According to Spaulding and Nolting (2006), there is
broad agreement that outcome should be measured and understood in multiple domains, and that
treatment of severely mentally ill populations should take multiple outcome domains that
account for important aspects of real world functioning into account. One of the purposes of this
study is to explore the utility of a potential measure of recovery as an outcome measure.
Recovery Measures
Researchers have attempted to measure this newer conceptualization of recovery in
several ways. A literature search for recovery measures yielded three recovery measures with
published reliability and validity estimates.
Recovery Assessment Scale. The Recovery Assessment Scale (RAS) is a 41-item likert
type scale designed to measure recovery (Corrigan, Giffort, Rashid, Leary, & Okeke, 1999). The
measure was developed from the narrative recovery stories of 4 consumers and then reviewed by
an independent group of 12 consumers to ensure that the items adequately identified the
construct of recovery (Corrigan, Salzer, Ralph, Sangster, & Keck, 2004). The RAS as exhibited
acceptable test retest reliability (r = .88) and internal consistency reliability (alpha = .93). In
addition, the RAS has also been shown to have acceptable concurrent validity with measures of
self-esteem and empowerment, as well as expected divergent validity when compared to the
Brief Psychiatric Rating Scale (BPRS) (Corrigan et al., 1999). In factor analysis, five factors
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emerged—personal confidence and hope, willingness to ask for help, goal and success
orientation, reliance on others, and no domination by symptoms.
The RAS has established external validity in terms of recovery as individual consumers
have defined it, but lacks the strength of a consensus definition of recovery. In addition, the
RAS has demonstrated acceptable reliability and validity estimates but lacks any established
utility for measuring changes in recovery over time.
Recovery Process Inventory. The Recovery Process Inventory (RPI) is a 22-item selfreport measure that utilizes a likert-type scale to assess recovery (Jerrell, Cousins, & Roberts,
2006). The measure is based on a 10-dimensional model of recovery which was derived from
four focus groups on recovery. The 10 dimensions in the model include Hope,
Empowerment/Self-control, Self-Esteem, Self-management, Social Relations, Housing,
Employment, Stigma, and Spirituality. The RPI has yielded internal consistency reliability
estimates from .71 to .81, and test re-test reliability estimates from .36 to .63. In the factor
analysis, six factors emerged: anguish, connected to others, confidence and purpose, others’ care
and help, good living situation, and hopeful/cares. Convergent validity with the Mental Health
Statistics Improvement Program Adult Consumer Survey (MHSIP) varied from fair to moderate
(.26 ≤ r ≤ .55).
While the RPI has yielded acceptable internal consistency reliability, it lacks test re-test
reliability within the acceptable range for an outcome measure. In addition, the measure is only
designed to be administered one time over the course of a year and has therefore not exhibited
any utility for measuring change. The measure also lacks external validity in terms of recovery
as a theoretical construct.
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Stages of Recovery Instrument. The Stages of recovery instrument (STORI) is based
on a model of recovery which incorporates four key component processes (finding and
maintaining hope, the reestablishment of a positive identity, finding meaning in life, and taking
responsibility for one’s life) and five stages of recovery—moratorium, awareness, preparation,
rebuilding, and growth) (Andresen, Caputi, & Oades, 2006). These components and stages were
derived via the analysis of several personal accounts of recovery in addition to five qualitative
studies that examined various stages of recovery. Concurrent validity for individual stages
ranged from r = 0.52 (p < 0.01) to r = 0.62 (p < 0.01), the measure was compared to the
Recovery Assessment Scale, the Mental Health Inventory, Psychological Well-Being Scales,
Connor Davidson Resilience Scale, Adult State Hope Scale, and the self-identified stage of
recovery as identified by the participants. The internal consistency for each of the sub-scales all
returned high alpha values (from α = 0.88 to α = 0.94). The researchers also found evidence for
divergent validity among the stages of recovery in that the most distal stages were negatively
correlated and the adjacent stages were positively correlated. There was also a relationship
demonstrated between the stage of recovery and a participant’s score on other mental health
assessments. Participants in the later stages of recovery tended to score higher on other mental
health measures supporting the hypothesis that recovery is a measurable progression. While the
STORI is likely useful as an ipsitive measure for identifying an individual’s particular stage in
recovery, it does not appear to have utility as a measure of recovery outcome in the sense that it
is able to track recovery at both individual and group levels.
The recovery model is currently lacking a measure that tracks the progress of recovery in
individuals and groups of individuals across time. In other words, there have been no measures
that have demonstrated the utility of tracking consumer outcome based on the recovery model.
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In addition, no recovery measure has been validated in a way that looks at existing theory and
empirical research outside of the recovery literature. Thus it is important to place recovery in a
theoretical and empirical context before explaining the methodological processes of the current
study.
Positive Psychology
An area of research that could provide recovery with such a nomoligical context is
positive psychology. According to N. Jacobson & Curtis (2000), policy makers have been
looking for practical ways to incorporate the philosophy of recovery into actual practice. One
way in which policy makers could go about this is by looking at existing research that may be
connected to the philosophy of recovery. In addition, it is also important for empirical research
to be grounded in both theory and empirical evidence. In other words, in order for effective
research to be done on the concept of recovery it is important to investigate whether there is
existing research on the aspects incorporated in the recovery movement to use as a context for
understanding recovery research.
Like the recovery model, positive psychology theory suggests that mental health and
mental illness may represent two separate but related spectrums (Keyes, 2007; Ryff, 1989; Ryff
& Keyes, 1995; Seligman, Peterson, Aspinwall, & Staudinger, 2003). Resnick and Rosenheck
(2006) identify a possible crossover between positive psychology and recovery. They suggest
that, even though the positive psychology and recovery movements have followed separate
paths, they have arrived at similar conclusions. They suggest that the recovery model could be a
means for expanding the application of the positive psychology movement. In addition, Anthony
(2003) argues that research on how all types of people change and grow could and should be
applied to recovery.
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Positive psychology research has been fueled by the idea that, in addition to abnormality,
what is good in life should be studied empirically (Compton, 2005; Froh, 2004; Gable & Haidt,
2005). According to Seligman (1998), psychology should not be the study of merely what is
broken but also the study what is good about life (Fowler, Seligman, & Koocher, 1999).
Researchers in positive psychology argue that focusing only on the study of mental illness is an
incomplete approach to psychological research because the absence of mental illness does not
necessarily indicate the presence of mental health (Keyes, 2007).
Seligman first introduced the positive psychology movement as an empirical movement
aimed at studying well-being in his keynote address of the 1999 annual conference of the
American Psychological Association (Fowler et al., 1999). In his speech, Seligman suggested
that it was not enough for psychology to focus solely on disorder: it required the study of the
whole individual. In response to his speech, a movement has begun within psychology dedicated
to understanding the positive side of life. The positive psychology movement has since grown
exponentially, yielding hundreds of published studies and articles (Seligman, Steen, Nansook, &
Peterson, 2005).
Gable & Haidt (2005) define positive psychology as a study of conditions or processes that
contribute to the flourishing or optimal functioning of people. Flourishing is understood to be
living within the optimal range of human functioning (Fredrickson & Losada, 2005). In other
words, to flourish is to be mentally healthy. Positive psychology has focused on understanding
human flourishing by focusing on such topics as strengths, virtues, resilience, well-being, and
others (Gable & Haidt, 2005; Keyes, 2007; Resnick, Warmoth, & Selin, 2001; Ryff, 1989; Ryff
& Keyes, 1995; Sawyer, 2002; Seligman et al., 2003).
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Some researchers have called for a positive psychology approach for clinical practice, a
clinical approach focusing on helping individuals to flourish rather than just on eliminating
symptomatic distress (Seligman et al., 2003). These researchers suggest that it is not enough for
those treating the mentally ill to focus on symptom amelioration—they must focus on helping
consumers flourish. According to Keyes (2007), flourishing and mental illness can exist together
in the same individual at the same time. In other words, reducing an individual’s symptoms of
mental illness does not ensure that there has been an improvement in their overall mental health.
Measurement Theory
In order to adequately evaluate the utility of a measure of recovery it is first necessary to
conduct a cursory review of measurement theory (i.e., the rules by wich psychological tests are
developed). There are three categories of psychological tests: discriminative, predictive, and
evaluative (Kirshner & Guyatt, 1985). Discriminative tests are used to distinguish between
individuals or groups on an underlying dimension when a gold standard is unavailable (Allen &
Yen, 1979). IQ tests and personality tests like the Minnesota Multiphasic Personality Inventory
are examples of discriminative tests because they categorize individuals based on scores.
Predictive tests are used to classify individuals into a set of predefined measurement categories
when a gold standard is available (Allen & Yen, 1979). Predictive instruments can be used
either concurrently or prospectively and are typically used as screening instruments to identify
which specific individuals have or will develop a target condition or outcome. An evaluative test
is used for the purpose of measuring the magnitude of longitudinal change in individuals or
groups on a dimension of interest (Allen & Yen, 1979). Measures designed to measure treatment
outcomes are evaluative because they are designed to track the progress and deterioration of
individuals receiving mental health treatment.
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Outcome measures have become an increasingly useful source of information about the
effects of treatment for researchers, practitioners, and insurance companies in the mental health
care community (Burlingame, Lambert, Reisinger, & Neff, 1995; Lambert, Gregersen,
Burlingame, & Maruish, 2004). Outcome measures have been fundamental to tracking the
efficacy of mental health treatment by tracking the progress of individual consumers in mental
health care settings (Lambert et al., 2004; Ogles, Lambert, & Fields, 2002). They have provided
researchers with a means to track the efficacy of individual therapists as well as the efficacy of
different forms of treatment (Okiishi et al., 2006; Okiishi, Lambert, Nielsen, & Ogles, 2003).
Outcome measures also provide some advantages to researchers when used in place of
controlled clinical trials because they allow clinicians and programs to have flexibility in how
they treat individuals as opposed to requiring them to practice based on highly specific manualbased treatments (Lambert et al., 2004). This allows clinicians to approach treatment as they
normally would, thus giving researchers a more accurate depiction of the effects of real
treatment. Outcome measures thereby provide researchers with evidence regarding the
effectiveness of treatment that is based on actual practice—practice based evidence. In addition,
outcome measures provide clinicians with information regarding their clients’ level of intake
functioning (Lambert et al., 2001; Wells, Burlingame, Lambert, Hoag, & Hope, 1996), their
progress in treatment (Lambert et al., 2001; Wells et al., 1996), and the effectiveness of specific
treatment interventions (Wells et al., 1996). Consequently, outcome measures provide mental
health care providers with realistic data regarding the efficacy of their programs.
In addition, increasing concern over costs and holding clinicians accountable has arisen
among health care providers and corporations (Burlingame et al., 1995). Outcome measures give
health care providers and third party payers with an opportunity to track therapeutic effectiveness
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and make adjustments accordingly (Lambert et al., 2004; Wells et al., 1996). This allows health
care providers to track the effectiveness of treatment without requiring practitioners to adhere to
specific treatment models or interventions, thus allowing practitioners the flexibility to use their
judgment to better help consumers. This tracking method, in turn, allows providers to track the
effectiveness of treatment at multiple levels (e.g., individual, unit, and organization).
Given the potential impact of outcome measures on consumers, clinicians, and providers
it is essential that such measures are both accurate and consistent in their measurements. For this
reason, it is important to ensure that outcome measures yield empirical evidence for both
reliability and validity (Wells et al., 1996).
Reliability. Reliability refers to how precise a test is, in other words, the degree to which
test scores are consistent and repeatable (American Psychological Association., American
Educational Research Association, & National Council on Measurement in Education, 1985).
Reliability is defined in classical testing theory as the degree to which an observed score matches
a participant’s true score (Allen & Yen, 1979). In this sense, the true score is a theoretical
representation of a test-taker’s true response to a given test, whereas the observed score is the
reported score from one administration of the test. In this sense, the reliability coefficient is one
estimate of the amount of error inherent in the measure because it is an estimate of the degree to
which reported scores differ from true scores (Allen & Yen, 1979). Low reliability resulting
from high error variance means that the probability that the observed score reflects a
participant’s true score is also low. Conversely, high reliability as a result of low error variance
suggests that the observed score more accurately represents the participant’s true score at the
time of measurement. Since a “true score” is a theoretical construct and is impossible to
calculate, reliability must be estimated.
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Reliability can be estimated in multiple ways. One method for estimating reliability,
which focuses on examining the inter-correlations among test items, is internal-consistency
reliability (Ghiselli, Campbell, & Zedeck, 1981). Internal-consistency reliability can be
estimated using only one test administration and avoids the problems associated with repeated
testing. The most widely used method for obtaining an internal consistency estimate for a
measure that has continuous part scores is the Cronbach’s Alpha statistic (Ghiselli et al., 1981).
Cronbach’s Alpha is a function of the ratio of the sum of the interitem covariances to the
variance of the total score of the measure. This sum is largely a function of the intercorrelations
among the items. Since the measure in question in the present study is thought to measure
dynamic variables, internal consistency reliability is considered the appropriate method for
estimating reliability (Ghiselli, et al., 1981).
Lambert, Hill, Bergin, & Garfield (1994) suggest that test-retest reliability is also
particularly important to outcome research. This is because outcome measures are typically
administered pre-treatment, during treatment, and post-treatment in an effort to track an
individual’s or group’s progress in treatment. The differences in these administrations are
typically calculated in order to represent some sort of change or progress in treatment. In order
for a test to do this, it must demonstrate the ability to track the effects of treatment in individuals
over time. Change scores are not represented solely in terms of an individuals true change score
but also in terms of random measurement error (Allen & Yen, 1979). An effective outcome
measure must therefore demonstrate acceptable reliability estimates in order to ensure that
change scores are not merely a result of error variance. Thus, an outcome measure with
acceptable test-retest reliability estimates should show change in groups receiving treatment that
has been proven to be effective, and no change in groups receiving no treatment. While test-
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retest reliability is important to the development of an outcome measure it is beyond the scope of
the current study.
Validity. An instrument is considered valid when it can be shown to measure what it
purports to measure (Allen & Yen, 1979). For example, if a measure is designed to assess a
particular construct like depression, then the items should be shown to effectively measure that
construct or multiple constructs if the measure is designed to measure multiple constructs. There
are a number of ways in which validity estimates can be calculated, including construct validity,
content validity, and criterion-related validity (Allen & Yen, 1979).
Construct validity is the degree to which an instrument accurately measures the
theoretical construct that it is designed to measure. A combination of various validity estimates
makes up the construct validity of an instrument. According to Allen and Yen (1979), construct
validity is an ongoing process and may include any stable prediction, both criterion and content
related.
Content validity is determined by subjective judgment based on rational analysis of the
content of a test. There are two main types of content validity: face validity, in which the test
items appear to measure the construct they purport to measure, and logical validity, in which a
panel of experts examines a measure according to specific criteria (Allen & Yen, 1979). Content
validity is not considered sufficient justification for a test’s use (Allen & Yen, 1979).
Criterion-related validity is determined by how well a test score predicts some type of
criterion or human behavior. In the case of recovery the criterion we are using is traditional
outcome. Theoretically, a high score on a recovery measure should correlate moderately with
symptom amelioration. There are two types of criterion-related validity: predictive validity,
which looks at how well a test predicts some type of future behavior, and concurrent validity,
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which looks at how well a test predicts behavior that is co-occurring at the time the measure is
give. Predictive validity involves using test scores to predict future behavior. A predictive
validity coefficient is obtained by giving the test to all relevant people, waiting a reasonable
amount of time, collecting criterion scores, and calculating the validity coefficient (Allen & Yen,
1979). This study will seek to explore the construct validity of a recovery measure in the areas
of criterion-related validity in the form of concurrent validity. Concurrent validity is obtained by
calculating the validity coefficient of two measures given at the same time.
Since construct validity is the degree to which a measure actually measures the trait or
characteristic that it purports to measure, it is important to assess the degree to which an outcome
instrument accurately identifies individuals that fall into clinical and non-clinical ranges (i.e.,
identify individuals that are more likely to be in need of mental health services). If a measure is
unable to distinguish between individuals that are likely to fall in either a clinical or non-clinical
population, then it would also not be useful in terms of distinguishing when an individual has
moved from being likely to fall in a clinical population vs. falling in a non-clinical population.
One way to investigate how well a measure does this is by calculating a clinical cut-off point.
The cutoff point is the numerical score between adjacent samples where it is statistically more
likely for a score to be in one, as opposed to the other adjacent overlapping sample (Jacobson et
al., 1984). A clinical cutoff score can be calculated by utilizing the means and standard
deviations of the two differing populations (in this case individuals in a clinical population vs.
individuals that are not). The equation for calculating the cutoff score is as follows:

Where SD1 is the standard deviation of the clinical (consumer) population, Mean2 is the mean of

Recovery Scale 20
the non-clinical population, SD2 is the standard deviation of the non-clinical population, and
Mean1 is the mean of the clinical population. Once a cutoff score has been calculated it is
important to assess its accuracy in terms of its ability to identify individuals that fall in each
population.
One of the ways to do this is by calculating the sensitivity and specificity of the instrument.
Both sensitivity and specificity were defined first by Yerushalmy (1947) and have been an
important part of the medical literature since that time (Griner, Mayewski, Mushlin, & Greenlan,
1981; Vecchio, 1966). Sensitivity, in this sense, can be understood as the degree to which a
measure accurately identifies individuals that possess the attribute of interest. In this case, it
would be the degree that a recovery measure accurately identifies consumers who function in the
clinical range, obtaining scores in the clinical range of the screening test as determined by the
cutoff score. Sensitivity is calculated by dividing the number of true positives (individuals
accurately identified as falling within the clinical range) by the sum of true positives and false
negatives (individuals inaccurately identified as not falling within the clinical range). Specificity
refers to the degree to which a measure is able to accurately identify consumers that fall in the
non-clinical range. It is calculated by dividing the number of true negatives by the number of
true negatives added to the number of false positives.
Sensitivity and specificity are estimated using different samples of people and vary
independently of one another. For this reason both sensitivity and specificity can be high and
approach the perfect case of a test that is 100% sensitive and 100% specific, or both can be low.
In addition, both indices are independent of sample size and population base rates.
In addition to sensitivity and specificity, it can also be helpful to examine the positive
predictive power and negative predictive power of an instrument (Griner et al., 1981). The
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positive predictive power of a test is the likelihood that a person with a positive test finding
actually falls into the identified population, in this case whether someone identified as belonging
in the clinical population actually is in a clinical population. Positive predictive power is
calculated by dividing the number of actual positives by the number of total positives, including
false positives, identified by the test. The negative predictive power of a test is the likelihood
that an individual that is not identified as falling within the clinical population actually does not
fall into the clinical population. Negative predictive power is calculated by dividing the actual
number of negatives by the total number of negatives, including false negatives, identified by the
test. When looking at both positive predictive power and negative predictive power, it is
important to consider that neither estimate is independent of sample size: both high and low
calculations of positive and negative predictive power could be the result of the number of
individuals that fall in either the clinical or non-clinical ranges.
Validity for change. Outcome measures are designed to track change in individuals
resulting from treatment. A measure may be a valid indicator of a characteristic without being
able to measure change in that characteristic (Lambert et al., 1994). For this reason, in order for
an outcome measure to be valid, its ability to detect change be demonstrated. According to
Lipsey (1983), validity for change can be demonstrated from the effect size when comparing
treatment groups and comparison groups from the same populations. The effect size for an
outcome measure is determined by calculating the difference between post-treatment means for
treatment and comparison groups divided by the outcome measure’s standard deviation. In other
words, the effect size as represented by d is a measure of the degree to which population means
of two samples differ (µ1 - µ2). Effect sizes are considered small when d = .20, moderate when d
= .50, and large when d = .80 or greater.
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Sensitivity to change. Sensitivity to change, or responsiveness, was first emphasized as
an important psychometric property in the 1970’s (Aiken, 1977). Guyatt, Walter, and Norman
(1987) defined responsiveness as an instrument’s ability to detect clinically important change
and suggested that a measure’s sensitivity to change is determined by two properties. First,
sensitive measures must yield more or less the same scores when subjects are stable. Second, it
must register score changes when subjects’ health status improves or deteriorates. They further
suggested that failure to demonstrate responsiveness is the product of one of two factors: either
treatment did not work or the instrument used was inadequate in assessing changes that occurred.
Deyo, Diehr, and Patrick (1991) viewed responsiveness as the ability of an instrument to detect
small but important clinical changes. Kazdin (1998) defined sensitivity as the ability of a
dependent measure to be sensitive to the type and magnitude of change that the investigator is
expecting. In this study, we expect to see a correlation between recovery and traditional
outcome. In other words, when consumer scores remain stable on a gold standard measure of
outcome, we would expect to see their recovery scores remain stable as well. In addition, as
consumers show improvement or deterioration as measured according to a gold standard
outcome measure, we would expect to see that improvement or deterioration reflected in their
scores as measured by the recovery measure.
In addition, an outcome measure must be sensitive to clinically significant change
(Jacobson, Truax, & Kazdin, 1992). Clinically significant change has been defined as a posttreatment return to normal functioning (Jacobson & Truax, 1991). This type of change can be
evaluated in three ways (Jacobson et al., 1992). First, post-treatment functioning of consumers
should fall outside the range of the dysfunctional population with the range defined as two
standard deviations beyond the mean for that population in the direction of functioning. Second,
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post-treatment consumer functioning should fall within the range of the functional population
with the range defined as within two standard deviations of the mean of that population. Third,
post-treatment consumer functioning should be closer to the mean of the functioning population
than the mean of the dysfunctional population.
This conceptualization of clinically significant change is somewhat problematic since the
recovery model posits that a return to normal functioning is unnecessary in order for consumers
to meet the criteria of having recovered. For this reason, there is a strong possibility that the
distributions of functional and dysfunctional as defined by the recovery model will exhibit a
great deal of overlap. Thus, it is essential to ensure that the changes measured by an instrument
are reliable (Jacobson et al., 1992). In order to ensure that this is the case, a reliable change
index (RCI) can be calculated. An RCI is calculated by subtracting consumer initial treatment
scores from post-treatment scores and then dividing them by the standard error of the difference.
The standard error of the difference describes the spread of the distribution of change scores that
would be expected if no actual change had occurred and is calculated by taking the square root of
twice the standard error of measurement of a distribution squared. According to Jacobson et al.
(1992), an RCI greater than 1.96 would be unlikely to occur (p < .05) without change that was
not due to chance alone. If the RCI is less than 1.96 then the measured change may be due to the
fluctuations of an imprecise measurement. Calculating an RCI will allow us to examine whether
the recovery measure in question is able to detect clinically significant changes in consumers that
are greater than would have occurred by chance alone (Jacobson et al., 1992).
Analysis of therapeutic change. Statistical methods are particularly important when
assessing change because different methods of analysis on the same data can lead researchers to
come to different conclusions about client data (Speer & Greenbaum, 1995). In order to evaluate
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change, a statistical procedure must be able to accommodate a multiple administrations or
repeated measures design. In addition, the method must be able to detect change at both the
individual and group levels.
Traditionally, univariate (ANOVA) or multivariate (MANOVA) analysis of variance
procedures have been used to track outcome (Raudenbush & Chan, 1993). According to Ware
(1985), the aforementioned analyses are inappropriate when studies of change contain missing
data, time-varying covariates, unbalanced designs or continuous predictors of rates of change. In
addition, these models do not directly model for individual variation, but instead account for it
only within interactions of repetitions. In contrast, hierarchical linear modeling (HLM) offers an
analytic approach without the limitations as MANOVA and ANOVA (Raudenbush & Chan,
1993).
HLM estimates linear equations that explain outcomes for members of groups at both
individual and group levels (Arnold, 1992). The models are hierarchical because they involve
predicting the characteristics of members who are nested within a group or a network of groups.
Each group may then be encompassed within a larger group. At each level, each member of the
group belongs to only one group at the next hierarchical level (Arnold, 1992). Most mental
health services are provided within nested groups, and a great deal of research on mental health
care involves tracking the effect that specific groups have on outcome. Consumers are often
placed in the care of therapists within mental health care systems that are often part of larger
health care organizations, and factors at each level of care delivery can affect consumer
outcomes. Since consumer growth or deterioration may occur within all of the aforementioned
levels, identifying the predictors of consumer growth is a multilevel problem.
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HLM involves performing regressions of regressions (Arnold, 1992). Therefore, it
presumes a working knowledge of linear regression analysis and its assumptions. The
regressions are done at the lowest unit of analysis (for example, consumers) within the next
higher unit of analysis (for example, therapists) and so on. At the first level, regression
equations for each consumer predict consumer outcomes as a function of other consumer
characteristics within each therapist or treatment center. These equations are called “withinunit” models, and there is one for each treatment center. The intercepts and coefficients in these
equations usually vary randomly across individuals and are used as the dependent variables in
second-level regression equations with individuals as the unit of analysis and individual
characteristics as the independent variables. These regression equations are called “betweenunit” models. HLM differs specifically from other slopes-as-outcomes methods in that HLM
accounts for the variance around each parameter from the first level in the regression analyses at
the next level (Arnold, 1992).
Research examining treatment trajectory growth curves is ideally suited to the use of
HLM that can be generated from consumer responses to outcome measure items (Arnold, 1992).
HLM growth curves allow the development of models of individual growth as well as the study
of differences between individuals in that growth because it allows for the examination of the
data at multiple levels. In addition, utilizing HLM for examining treatment trajectories in this
way has several advantages for use in outcome research over regression or MANOVA. HLM’s
use of the expectation-maximization algorithm accounts for missing data so that missing
participant data does not need to be thrown out because of the limitations of the model (Speer &
Greenbaum, 1995).
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In addition, HLM exhibits greater precision for assessing individual and group changes
because of the use of Bayesian estimation (Raudenbush & Chan, 1993; Speer & Greenbaum,
1995). HLM also is more flexible in terms of its data requirements because of nesting
(Raudenbush & Chan, 1993; Speer & Greenbaum, 1995). The repeated observations in HLM are
hierarchical, and thus participants may be analyzed at different times and on varied occasions—
each observation being viewed as nested within each individual participant (Bryk &
Raudenbush, 1987). In other words, HLM allows for the examination of a longitudinal data set
that utilizes consumer data comprised of varying waves of data points and administration
intervals. HLM is therefore an improvement on ANOVA and MANOVA because it utilizes all
available data (Speer & Greenbaum, 1995).
HLM does, however, require that certain assumptions about the data be satisfied for its
use. The first level of analysis requires at least three within-subject data points. The data must
consist of units nested within groups (hierarchical). The data from the first level of analysis form
the basis for the second level of analysis so they must be highly reliable and valid. The groups
must have enough within-subjects and between-subjects classifications to provide adequate
degrees of freedom. Large samples are recommended, but specifications on how large are not
given in the literature (Arnold, 1992). HLM involves a regression of a regression therefore no
assumptions about causation can be applied to HLM results (Arnold, 1992).
Statement of Purpose
The present study seeks to investigate the relationship between the new and old
conceptualizations of recovery and whether consumers with aspects of the recovery model
emphasized in their treatment actually experience greater symptom amelioration than consumers
not receiving that type of treatment. This study will be correlational, so it will not be able to
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establish a controlled treatment comparison; however, it will provide an initial empirical
opportunity for investigating the recovery model. In order to assess whether consumers are
progressing in treatment according to the standard outlined in the recovery model, it is necessary
that a measure yield both acceptable reliability and validity estimates. In addition, it is necessary
that such an instrument demonstrate the ability to detect changes in consumers over time. The
purpose of this study is to address the reliability and validity of the Utah Recovery Scale (URS).
Because no existing quantitative research has been done utilizing the URS, the aims of the study
can be better understood in terms of research questions rather than hypotheses:
1. Is there evidence supporting the reliability of the URS?
a. What evidence is there for the internal-consistency reliability of the URS (.8 or
greater)?
2. Is there evidence supporting the construct validity of the URS as a measure of mental
health treatment outcomes?
a. What evidence is there for the concurrent validity of the URS?
b. What is the relationship between recovery as measured by the URS and traditional
mental health treatment outcome as measured by the OQ-45?
c. What is the relationship between recovery as measured by the URS and wellbeing as measured by the quality of life items on the OQ-45?
d. Is there evidence that the URS can distinguish between consumers that fall in
clinical and non-clinical ranges?
e. What is the sensitivity and specificity of the URS?
f. Is there evidence that the URS is sensitive to clinically meaningful changes in
consumers?
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g. Are changes in individual consumers over time using the URS and its individual
items significantly different from zero?
h. Are the changes in consumers observed utilizing the URS greater than would have
occurred by chance alone as indicated by the reliable change index of the
instrument?
i. How do changes observed in consumers using the URS compare to changes in the
same consumers using the OQ-45?
Method
Phases of Empirical Examination
In order to answer the above research questions it was necessary to examine the URS in
two phases. The first phase of the study was to collect community data for the URS in order to
obtain URS data of a non-clinical sample. The next phase of the study was to examine archival
URS and OQ-45 data obtained through the state of Utah.
Phase 1: Community Sample. In order to calculate a clinical cut point, URS data from a
non-clinical community sample was collected.
Participant selection. Participants were selected randomly using a local phone book.
Trained researchers contacted participants via telephone and administered the survey according
to an administration script (see Appendix F). A total of 91 participants were sampled including
53 women and 38 men. Participant ages ranged from 18 to 86 with the average age being 44.
Data was not collected for individuals under the age of 18. Demographically, 84 participants
identified themselves as Caucasian, 2 as African American, 2 as Asian, 1 as Polynesian, 1 as
Latino, and 1 as Mixed Race. All participants indicated that they were not currently receiving
any form of mental health treatment.
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Instrument. The initial phase of the study examined the data collected using the Utah
Recovery Scale (URS). The URS was derived from a series of consumer focus groups conducted
by the Utah division of the National Alliance for the Mentally Ill (NAMI-Utah) in order to
construct questions based on SAMHSA’s fundamental components of recovery. The focus
groups resulted in 10 questions based on SAMHSA’s fundamental recovery components of Self
Direction, Individualized and Person-Centered, Empowerment, Holistic, Non-Linear, Strengths
Based, Peer Support, Respect, Responsibility, and Hope (SAMHSA, 2005). The URS is scored
using a 5-point scale (0= never 1 = rarely, 2 = sometimes, 3= frequently, 4 = almost always),
which yields a possible range of scores from 0 to 50.
Data collection. The URS currently has no developed reliability or validity statistics.
Initial criterion validity for the measure, however, was investigated using additional consumer
focus groups which pilot tested the measure. Participants for three focus groups were selected at
three different community mental health locations. Two of the focus groups consisted of patients
receiving inpatient treatment; the other consisted of participants receiving outpatient treatment.
Focus groups ranged from 5 to 15 participants, comprising of a total of 30 participants. The
focus group participants, after granting their consent to participate in the focus groups, were
asked to take the URS and then were asked questions about their experience taking the survey,
the survey questions, and about what recovery means to them in general. The focus group leader
closely followed a discussion guide of questions and asked follow-up questions when
appropriate. The groups lasted between 35 and 50 minutes and were digitally recorded for
further analysis. The discussion leader reviewed the digital recordings in conjunction with his
notes from the focus groups and analyzed them for emerging themes that were common among
focus groups.
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Response to the URS from the focus groups was, for the most part, overwhelmingly
positive. Almost all of the consumers felt that the questions addressed things that were important
to them—something that they did not always feel other outcome measures they had been
exposed to had done. Many also expressed that the measure addressed specific concerns that
were important to them and to their treatment.
Phase 2: Clinical sample. In order to calculate a clinical cut point, RCI, sensitivity and
specificity, and longitudinal change trajectories a clinical archival data sample was also
examined.
Archival data. Consumer data for this study was taken from the archival records of
community mental health centers in the state of Utah. Utah regularly tracks consumer outcome at
community mental health centers that receive state funding using a variety of measurement tools
including the Outcome Questionnaire-45 (OQ-45) and the URS. Consumer data are then
databased and reported back to clinicians using the OQ-45 analysis system that was developed
and supported by OQ-45 Measures LLC. This database provides patient-level demographic data
combined with outcome data for each consumer. Approximately 30,000 adults receive mental
health services from the state services on a yearly basis. Outcome data from inpatient,
residential, and outpatient consumers was analyzed.
Instruments. In addition to the URS, this phase of the study also examined consumer
distress as measured by OQ-45, which is designed to measure client outcomes in a therapeutic
setting (Lambert et al., 2004). The OQ-45 is a 45-item self-report questionnaire scored using a
5-point scale (0= never 1 = rarely, 2 = sometimes, 3= frequently, 4 = almost always) and yields a
possible range of scores from 0 to 180. High scores on the OQ-45 indicate more distress and as
clients improve scores decrease. The OQ-45 has three subscales that measure the quality of
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interpersonal relations, social role functioning and symptomatic distress. The OQ-45 has been
validated across cultures using a variety of normal and consumer populations (Lambert et al.,
2004). The OQ-45 has become a gold standard for measuring symptomatic distress as it relates to
treatment, and was recently found to be the third most commonly used measure of outcome in a
survey by psychologists in clinical practice (Hatfield & Ogles, 2004). In addition, the OQ-45 has
demonstrated utility for tracking a client’s progress in therapy as well as measuring therapist
effectiveness (Okiishi et al., 2006; Okiishi et al., 2003; Vermeersch, 1998; Vermeersch, Lambert,
& Burlingame, 2000; Vermeersch et al., 2004).
The OQ-45 takes approximately five to seven minutes to complete and is typically
administered prior to each treatment session. Concurrent validity is moderate to high (r = 0.50–
0.85) when correlated with measures most often used to assess psychotherapy outcome in
clinical trials (Lambert et al., 2004). Most importantly, the OQ-45 has been shown to be
sensitive to changes in clients over short time periods while remaining stable in untreated
individuals (Vermeersch, Lambert, & Burlingame, 2000; Vermeersch et al., 2004). The OQ-45
has a reported three-week test-retest reliability value of r = .84 and a reported internal
consistency of r = .93 (Lambert et al., 2004).
Reliable change indices (RCI) for the OQ-45 have been calculated using formulas
developed by N. S. Jacobson and Truax (1991). The RCI for the OQ-45 was calculated to be 14
points using normative data from the community non-clients (N = 1353) and clients entering
treatment (n = 1476), thus clients who exhibit a 14 point positive or negative change are found to
have made reliable change. A clinical cutoff score on the OQ-45 was found to be 63; thus, when
a client’s score drops below 63, they are thought to be functioning more like non-clients than
typical client populations. When a client’s score has dropped by 14 points or more and the
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clinical cutoff score has fallen below 63, the client has met the criteria for clinically significant
change (Ellsworth et al., 2006).
In addition to the total score, the OQ-45 has three subscales that measure quality of
interpersonal relations, social role functioning and, symptom distress (Lambert, et al., 2004). The
interpersonal relations subscale consists of 11 items that attempt to assess functioning in
interpersonal relationships. The social role subscale consists of nine items that measure
dysfunction in roles such as work and leisure life activities. The final subscale, the symptom
distress subscale, is a 25-item scale that evaluates symptoms such as depression and anxiety.
Research Questions
In order to assess whether consumers are progressing in treatment according to the
standard outlined in the recovery model, it is necessary that a measure yield both acceptable
reliability and validity estimates. It is also necessary that such an instrument demonstrate the
ability to detect changes in consumers over time. The purpose of this study was to address the
reliability and validity of the URS in addition to the measure’s ability to detect clinically
meaningful changes over time. Since no prior empirical data has been collected for the URS,
this study is better understood in terms of the following research questions, rather than
directional hypotheses, were explored:
•

What is the internal consistency reliability for the URS?

•

What is the relationship between the URS and traditional outcome as measured by a gold
standard measure of outcome (OQ-45)?

•

Is the URS capable of measuring clinically meaningful change as statistically defined
using a Reliable Change Index (Jacobson & Truax, 1991).
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•

How do meaningful changes in consumers as measured by the OQ-45 over a six-month
period and changes measured in the same consumers over the course of the same time
period by the URS relate to one another?

Several analyses were used in order to answer these questions. First, the internal consistency
of the URS was calculated from the non-clinical data sample using the Cronbach’s Alpha
statistic. Second, correlational procedures were used to compare the URS and the OQ-45 based
on a one-time administration of the measures in a clinical consumer sample. Third, both the
clinical and non-clinical samples were used to calculate a cutoff score. Fourth, clinical
longitudinal data were used to calculate an RCI for the URS that was then used to compare
consumer change classifications on both instruments. Lastly, consumer change trajectories on
both measures were examined and compared utilizing hierarchical linear modeling.
Results
Data for this study was examined in three areas: reliability analyses from a community
sample, single administration analyses exploring the relationship between the URS and the OQ45 in a clinical sample, and longitudinal analyses of the relationship between consumer change
as measured by the two instruments.
Reliability
In order to explore the reliability of the URS, participants were randomly selected from
the community. After agreeing to participate in the study and giving consent participants
answered a few demographic questions and then the 10 URS items over the phone. The internal
consistency for the URS scores was estimated using the Cronbach’s alpha statistic. Six
participants who indicated that they were currently receiving some form of mental health
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treatment were excluded from this analysis. The overall URS internal consistency estimate was
high (α = 0.898, n = 91).
Single Administration Analyses
Archival single administration consumer data from community mental health centers in
Utah were used to explore the relationship between the URS and the OQ-45. This data was
explored in terms of an overall relationship between the two measures, the relationship between
the subscales of the OQ-45 and the URS, and the relationship between the quality of life items on
the OQ-45 and the URS.
Initial analyses indicated a strong inverse relationship between the two measures (r = 0.75, n = 8,483). This indicates that consumers who scored higher on recovery as measured by
the URS scored lower on distress as measured by the OQ-45. In addition, several individual
items from the two measures had moderately strong negative correlations (r < -.6), which are
reported in Table 1.
In addition, moderate to strong relationships were also found between the URS and each
of the OQ-45 subscales: Symptom Distress (-.711, n = 7878), Social Role Functioning (-.576, n
= 8,197), and Interpersonal Relations (-.746, n = 8162). Consumers with missing scores on these
particular items were excluded from this analysis.
The OQ-45 also contains several positively worded items that are reverse scored that can
be considered quality of life items. As with the rest of the OQ-45, higher scores on these items
are indicative of higher levels of distress. A composite score was created from these items and
then compared with the URS total score. A strong inverse relationship was shown between the
quality of life items (higher scores indicate higher levels of distress) and the URS (higher scores
indicate higher levels of recovery; r=-.863, n= 8,216). Consumers with missing scores on these
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Table 1
Item Correlations Between the OQ-45 and the URS
URS items
OQ-45 items
1. I have hope for the future. 13. I am a happy person.
15. I feel worthless.
23. I feel hopeless about the
future.
24. I like myself.
31. I am satisfied with my life.
OQ-45 total
2. Most days I get to do
something that I enjoy.
—
3. I do something I enjoy
during the day.
21. I enjoy my spare time.
31. I am satisfied with my life.
OQ-45 total
4. I feel the place I live is ok.
—
5. My life has meaning.
13. I am a happy person.
20. I feel loved and wanted
24. I like myself.
31. I am satisfied with my life.
OQ-45 total
6. I have people/friends that I
can turn to.
20. I feel loved and wanted
7. I am connected to my
community.
—
8. I am in charge of my own
life and recovery.
—
9. I have goals for my future.
—
10. My relationships are
meaningful.
20. I feel loved and wanted
43. I am satisfied with my
relationships with others.
URS total
3. I feel no interest in things.
13. I am a happy person.
20. I feel loved and wanted
21. I enjoy my spare time.
24. I like myself.
42. I feel blue
43. I am satisfied with my
relationships with others.
Note. — indicates that correlations for that item were weaker than .6.

r
-0.634
-0.615

n
8739
8738

-0.671
-0.643
-0.67
-0.67

8746
8742
8761
8750

—

—

-0.65
-0.611
-0.619
—
-0.624
-0.617
-0.638
-0.683
-0.648

8726
8744
8734
—
8714
8731
8716
8736
8724

-0.612

8722

—

—

—
—

—
—

-0.632

8717

-0.617
-0.612
-0.709
-0.702
-0.663
-0.706
-0.608

8705
8474
8483
8491
8483
8487
8495

-0.692

8486
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Table 2
Correlations Between the Quality of Life Items and the OQ-45.
URS
OQ-45
1. I have hope for the
13 I am a happy person.
future.
24 I like myself.
31 I am satisfied with my life.
3. I do something I enjoy
21 I enjoy my spare time.
during the day.
31. I am satisfied with my life.
5. I have meaning in my
life.
10. My relationships are
meaningful.
URS Total

13 I am a happy person.
24 I like myself.
31 I am satisfied with my life.
20 I feel loved and wanted.
43 I am satisfied with my
relationships with others.
Positive item composite score

r

n

-0.634
-0.643
-0.67

8739
8742
8761

-0.65

8726

-0.611

8744

-0.624
-0.638
-0.663

8714
8716
8736

-0.632

8717

-0.617
-0.863

8705
8216

particular items were excluded from this analysis. Individual items that were found to have a
moderately strong relationship (r<-.6) are reported in Table 2.
Longitudinal Analyses
Archival longitudinal consumer data from community mental health centers in the state
of Utah were explored in order to assess the URS’s ability to detect clinically significant changes
among consumers. The data was examined in several ways including the calculation of a cutoff
score, a reliable change index, and calculations of longitudinal consumer change trajectories.
The longitudinal sample used for these analyses consisted of 1,445 consumers that took the URS
over several administrations ranging from 2 to 16, with the average number of administrations
being 3.5.
Cutoff score. The first step in this process was to calculate a cutoff point—the point
along the range of possible URS scores that best separates the distribution of the non-consumer
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population scores from the distribution of consumer population scores. The cutoff point between
adjacent samples defines the point where it is statistically more likely for a score to be in one, as
opposed to the adjacent overlapping distribution (Jacobson et al., 1984). The calculation is as
follows:

Where SD1 is the standard deviation of the clinical (consumer) population, Mean2 is the mean of
the non-patient population, SD2 is the standard deviation of the non-patient population, and
Mean1 is the mean of the clinical (consumer) population. In order ensure homogeneity in the
consumer sample, consumers whose OQ-45 score fell below the clinical cutoff of 63 were
excluded from the analysis. Descriptive data for these two samples on the URS are reported in
Table 3.
Table 3
Descriptive Data for the Community and Clinical Samples
Sample
Mean
SD
n
Clinical
19.67
7.072
5,010
Community 35.84
5.455
91
Prior to calculating a cutoff point, it was necessary to ensure that both samples used in the
calculation were statistically distinct. Distinctness of the samples was determined using an
independent samples t test and a “d” test. The two samples met the two criteria for statistical
distinctness. The independent samples t value of -27.841 (p<.05, df =95.577) surpassed alpha of
.05. Equal varaiances were not assumed for this calculation providing a more conservative
estimate of t. In addition, the calculated “d” value surpassed the criterion of .5, further indicating
the distinctiveness of the two samples (d=2.56). Once distinct samples were identified and
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statisically verified, the next step of generating a cutoff point was completed. Using the above
formula a cutoff score of 28.799 (28/29) was calculated.
The clinical cutoff score enables the URS to distinguish consumers from non-consumers.
Table 4 presents the acuracy with which the cutoff score classified respondents. The sensitivity
of .89 indicates that 89% of actual patients scored below the clinical cutoff score of 29 and 11%
scored above. In other words, use of the cutoff score identified 89% of actual consumers. The
specificity of .95 indicates that of the actual non-consumers, 95% scored above the cutoff score
and 5% scored below. Thus the cutoff score identified 95% of actual non-consumers. The
overall accuracy of the cutoff score in predicting patient versus non-patient status was 0.89 (hit
rate). The positive predictive power (PPP) of .99 indicates that of the cases the cutoff score
predicted to be patients, 99% of them were actual patients. The negative predictive power (NPP)
of .14 indicates that of the cases the cutoff score predicted to be non-patients, 14% of them were
actual non-patients. Note that whereas the test characteristics of sensitivity, specificity, and hit
rate are relatively independent of prevalence of the condition being tested, the characteristics of
PPP and NPP are highly dependent upon prevalence (Streiner, 2003). Thus the high PPP and
low NPP are expected considering the large proportion of consumers (98%) versus nonconsumers (2%) in the sample producing these indices.
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Table 4
Sensitivity and Specificity of the URS Clinical Cutoff Score
Actual
Positive
Negative
(non(consumer)
consumer)
True
False
Positive
Positives
Positives
(consumer)
86
536
Predicted
Negative
False
True
(nonNegatives
Negatives
consumer)
5
4474
91
5010
Total
2%
98%

Sensitivity
0.89

Specificity
0.95

Hit Rate
0.89

Positive
Predictive
Power
0.99

Total

622
12%
4479
88%
5101
100%
Negative
Predictive
Power
0.14

Reliable change index. In addition to a cutoff score, a reliable change index (RCI) was
also calculated for the URS. The RCI is a way of determining whether changes observed on a
measure are greater than what would be attributed to measurement error. The RCI is calculated
by multiplying the standard error of the difference by the point location on a distribution in order
to achieve a certain confidence interval. The RCI for the URS was calculated at the 95%
confidence level. In addition, the reliability coefficient used in the equation was Cronbach’s
alpha coefficient of .898, obtained from the community sample. The equation for calculating the
RCI is presented below:
95%𝑅𝐶𝐼 = 𝑆𝑑𝑖𝑓𝑓 = (4.095)(1.96) = 8.026 = 8/9
𝑆𝑑𝑖𝑓𝑓 = �2(𝑆𝐸 )2 = �2(2.896)2 = 4.095

𝑆𝐸 = 𝑆𝐷𝑝 √1 − 𝛼 = 9.066√1 − 0.898 = 2.896

(1542 − 1)(8.983) + (1445 − 1)(9.1554)
(𝑛1 − 1)(𝑆𝐷12 ) + (𝑛2 − 1)(𝑆𝐷22 )
=�
= 9.066
(1542 + 1445 − 2)
(𝑛1 + 𝑛2 − 2)

𝑆𝐷𝑝 = �
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where 95% RCI is the RCI value at the 95% confidence level, Sdiff is the standard error of the
difference, SE is the standard error of measurement, SDp is the pooled standard deviation for the
first and last score used in the calculation, α is the internal consistency reliability utilized for the
calculation, n1 is the sample size for the first administration, n2 is the sample size for the last
administration, SD1 is the standard deviation of the first administration of the URS, and SD2 is
the Standard deviation of the last administration of the URS. The calculated RCI for the URS
was 8.026 indicating that consumers who have changes greater than 8 points in their total URS
score have made clinically significant change.
The RCI and the cutoff score were then used in order to determine consumer improvement,
deterioration, and stability. In addition, consumers that reached the clinical cutoff score of
greater than 31 were considered recovered. Consumers whose first and last scores did not have a
corresponding OQ-45 score because of missing data were excluded from this analysis. The
results are presented in table 5.
Table 5
URS Change Status
Total
Recovered
No change
Improved
Deteriorated

n
1445
176
1114
67
88

% of total
100%
12%
77%
5%
6%

Change trajectories. Longitudinal consumer change trajectories were also examined.
First, consumer URS change trajectories were compared with zero (no change), and lastly
consumer URS change trajectories were compared with consumer change trajectories on the OQ45.
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In order to examine whether changes observed on the URS were significantly different
from no change consumer URS change trajectories were compared to zero or no change. HLM
was used for this analysis in order to account for the multiple waves of consumer data as well as
missing data. All but three (items 4, 6, and 10) of the URS items were shown demonstrate
change that was significantly different from zero. The results are presented in Table 6.
Consumer change trajectories on the URS were then compared to consumer change
trajectories on the OQ-45 in order to explore whether the two measures appear to be measuring
change in the same way.
Table 6
URS Total and Individual Item Slopes Compared to Zero
Item
Total
1. I have hope for the future.
2. I have meaningful work/volunteer activities in my life.
3. Most days I get to do something that I enjoy.
4. I have a place to live and it's ok.
5. My life has meaning.
6. I have people/friends I can turn to.
7. I am connected to my community
8. I am in charge of my own life and recovery.
9. I have goals for the future.
10. I have meaningful relationships
N = 1954
*p<.05.

Slope
0.07654
0.04967
0.06763
0.07075
0.01913
0.0747
0.02135
0.075
0.07862
0.05082
0.02817

t
5.87*
3.18*
4.03*
4.47*
1.16
5.16*
1.36
4.99*
4.57*
3.48*
0.078

Prior to conducting these statistical analyses, reverse scoring procedures were performed so that
increasing scores corresponded to increasing levels of psychopathology on all URS items.
In addition, scores from the two tests were standardized using Z scores so that both measures
were on an equal scale. Again, HLM was used for the analyses because of the multiple waves of
consumer data and to account for missing data. Results of the initial data analysis indicated that
in the overall consumer sample the URS seems to track change in the theoretically proposed
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direction (i.e., consumers improved over time at a similar rate as measured by the OQ-45). In
groups in which the slopes of the two measures were statistically different, the OQ-45
consistently had a steeper slope. The results of these comparisons are presented in Table 7 and
Appendix D.
Table 7
Slope Comparisons by Change Classification Between the URS and the OQ-45
Classification
Slope URS Slope OQ-45
n
t
Total
-0.079204
-0.08045
1954
0.09
Distressed
-0.14791
-0.1921
1151
2.74*
Distressed improved
-0.3765
-0.5247
203
4.07*
Distressed deteriorated
0.37348
0.4402
142
-1.23
Distressed no change
-0.04298
-0.02063
612
-1.19
Distressed recovered
-0.5831
-0.7751
190
4.19*
Not distressed
0.03121
0.09269
798
-2.48*
Not distressed improved
-0.2646
-0.4318
122
2.76*
Not distressed deteriorated
0.7459
0.4733
177
-4.65*
Not distressed no change
-0.03566
0.01192
498
-1.73
Beginning treatment
-0.12559
-.016657
685
1.53
Note. 5 cases could not be classified as distressed or not distressed because they were missing
their initial OQ-45 score and were therefore excluded from subsequent analyses.
5 additional consumers could not have change statuses calculated because of missing data and
were excluded from subsequent analyses.
*p<.05.
Discussion
The purpose of this study was to psychometrically examine the utility of the URS as an
evaluative measure for mental health treatment services. Evaluative measures such as the URS,
which are designed to track treatment progress, have the potential to greatly impact the treatment
that consumers receive by providing incremental feedback to both clinicians and service
administrators regarding client progress in treatment. Given this potential impact of evaluative
measures on consumers, clinicians, and providers, it was necessary to explore both the reliability
and the validity of the URS as an evaluative measure. The URS was examined in several
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psychometric categories including reliability, validity, sensitivity to change, and validity for
change. Two sets of URS data were utilized in order to examine questions of reliability and
validity about the instrument. First, data were collected from a randomly sampled community
population that was not receiving any kind of mental health treatment in order to explore the
reliability of the URS. Next, archival URS data collected from mental health consumers in the
state of Utah were also examined in order to answer questions regarding the validity of the
measure as well as the measure’s ability to detect clinically meaningful changes among
consumers receiving mental health treatment.
This chapter will explore the results of this study and potential interpretations of those
results. In addition, possible implications of the observed relationship between recovery as
measured by the URS and distress as measured by the OQ-45 will also be explored. This chapter
will proceed in the following order: reliability, validity, clinical implications, and limitations.
Reliability
In order to explore the utility of the URS as an evaluative measure it was first necessary
to explore the reliability of this measure, or in other words to answer the question of whether the
URS is consistent in its measurements. Reliability refers to how precise a test is, or the degree to
which test scores are consistent and repeatable (American Psychological Association, American
Educational Research Association, & National Council on Measurement in Education, 1985).
Since the measure in question in the present study is thought to measure dynamic variables,
internal consistency reliability is considered the appropriate method for estimating reliability
(Ghiselli, Campbell, & Zedeck, 1981). The obtained internal consistency estimate of α = 0.898
(n = 91) provides initial evidence for the reliability of the URS as it is above the .8 standard at
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which measures are thought to be reliable. In other words, there is initial evidence that the URS
is consistent in its measurements.
Validity
The Validity of the URS was examined in terms of its construct validity, sensitivity and
specificity, sensitivity to change, and validity for change.
Construct validity. In addition to reliability, it is also important to explore an evaluative
measure’s validity. In other words, does the measure sufficiently measure what it purports to
measure? In this case, is the URS able to measure recovery? More specifically, we were
interested in exploring the construct validity of the URS, which is the degree to which an
instrument accurately measures the theoretical construct that it is designed to measure.
In this study we examined evidence for the construct validity of the URS by first
exploring the criterion related validity of the URS. Theoretically, a high score on a recovery
measure should have a moderate negative correlation with consumer distress. Criterion-related
validity is determined by how well a test score predicts some type of criterion or human
behavior. In the case of recovery the criterion we are using is both consumer distress and
consumer quality of life as they are measured by the OQ-45.
Initial analyses indicate a strong inverse relationship between the URS and the OQ-45
measures (r = -0.75, n = 8,483). This strong relationship provides evidence that consumers with
higher distress scores are likely to have lower recovery scores and vice versa. In other words
consumers that have high recovery scores are likely to report low levels of distress. This
relationship provides some evidence for the construct validity of the URS in the sense that
recovery and distress are thought to be inversely related. This conclusion is also supported by
the URS’s strong relationship to the Symptom Distress subscale of the OQ-45 (r = -.711, n =
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7878). However, this stronger than expected relationship may also provide evidence that the
constructs of recovery and consumer distress actually overlap to an extent that measuring
recovery separately may be unnecessary. In addition, this relationship may also provide
evidence that consumers receiving recovery-focused treatments are more likely to show
improvement on the OQ-45. However, since these relationships are correlational, more research
is needed in order to further explore these possibilities. In addition, the URS’s demonstrated
strong relationship to the OQ-45 subscale of Interpersonal Relations (r=-.746, n=8162) and
moderate relationship to the OQ-45 subscale of Social Role (r=-.576, n=8197) provide further
evidence for the construct validity for the URS by demonstrating that consumers exhibiting
higher levels of recovery exhibit lower levels of relationship problems and lower levels of role
dissatisfaction.
In addition, a strong inverse relationship was shown between the reverse scored quality of
life items (higher scores indicate higher levels of distress) and the URS (higher scores indicate
higher levels of recovery) (r=-.863, n= 8,216). This strong relationship indicates that recovery
seems to be highly related to consumer quality of life as expected. This strong relationship
provides initial evidence for the possible link between recovery and factors that may contribute
to well-being, as it is discussed in the positive psychology literature since the quality of life items
ask questions which address perceived well-being, engagement and social relationships.
Sensitivity and specificity. It is also important for the construct validity of this type of
measure that the measure accurately identify consumers as being in a clinical or non-clinical
population (Glaros & Klein, 1988). For this reason it was important to explore the sensitivity
and specificity of the URS. Sensitivity is the capacity of a measure to yield a positive result for a
person with a clinical condition of interest (in this case whether a consumer of mental health
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services is accurately identified as being part of a clinical population). In the case of the URS it
would be the number of individuals that fall below the clinical cutoff score of 29. Similarly,
specificity refers to the capacity of a measure to accurately identify someone who is not a
consumer as not falling within a clinical population (Yerushalmy, 1947). In the case of the URS
it would be non-consumers who score over the cutoff score of 29. In general, as the ability of the
test to discriminate diagnostic groups of interest increases, so do its sensitivity and specificity.
The URS was generally accurate in both its identification of actual consumers (sensitivity
= .89) as well as its identification of actual non-consumers (specificity = .95). The ability of the
URS to identify both patients and non-patients suggests utilizing a cutoff score could be used to
help identify when consumers move from a clinical population to a non-clinical population
throughout the course of treatment. The ability of the URS to capture these differences
contributes to the construct validity of the URS because the measure differentiates consumers
approaching recovery from consumers who are not. The PPP of .99 indicates that of the cases
the cutoff score predicted to be patients, 99% of them were actual patients, and the NPP of .04
indicates that of the cases the cutoff score predicted to be non-patients, 14% of them were actual
non-patients. These indices are less useful in psychometric evaluation because they are largely
contingent on the sample sizes used to calculate them (Streiner, 2003). In other words, because
the clinical sample used was so much larger than the non-clinical sample, the positive and
negative predictive power for the URS are less meaningful.
Given the conceptualization of recovery as a life-long process, it may be helpful to think
of the cut score for the URS in terms of individuals scoring closer to one type of population
(consumer) than another (non-consumers) rather than in terms of individuals possessing a
specific diagnostic characteristic or disorder. In this way the cut score may be useful to
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clinicians in order to help them identify consumers that are experiencing aspects of recovery that
help them live meaningful, independent lives that are similar to individuals not receiving
treatment.
Sensitivity to change. In addition to criterion-related validity, it is also important for an
evaluative measure intended to track consumer progress in treatment to have the ability to detect
consumer changes throughout the course of treatment. This is because a measure may be a valid
indicator of a characteristic without being able to measure change in that characteristic (Lambert
et al., 1994). Kazdin (1992) defined sensitivity for change as the ability of a dependent measure
to be sensitive to the type and magnitude of change that the investigator is expecting.
In order for there to be evidence of the construct validity of the URS as an evaluative
instrument it must register score changes when consumers’ health statuses improve or
deteriorate. For this reason it was necessary to explore whether the URS was sensitive to
changes among consumers in treatment. In order to investigate the URS’s ability to detect
change, the URS was compared against 0 (no change). As a whole, the URS was demonstrated
to be significantly different from zero when tracking consumers in treatment over time. The
observed changes also occurred in the theoretically specified direction (i.e., consumers in
treatment improved over time).
In terms of the individual URS items, all 10 of the items demonstrated change in the
theoretically specified direction in that they had positive slopes; however, only seven of the 10
items demonstrated a rate of change that was statistically significant when compared to zero.
This finding provides evidence that both the URS as a whole the seven items can detect changes
in consumers in treatment over time. The three items that were not demonstrated to be able to
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detect change when compared to zero were “I have a place to live and it’s ok,” “I have
people/friends I can turn to,” and “I have meaningful relationships.”
There are a number of possibilities that may have contributed to the inability of these
items to detect changes in consumers that were significantly different from zero over time. One
possibility is that these questions are poor indicators of aspects of consumers’ lives that are likely
to change during mental health treatment. Another possibility is that outside consumer
relationships and living situations are not emphasized enough in the mental health treatment
programs in Utah for there to be measurable changes made by consumers in those areas. A third
possibility is that the areas that these items measure may change more slowly over time than the
other areas measured by the URS. In other words, if we tracked consumers for a longer period of
time perhaps significant changes in these areas might be observed. Yet another possibility could
be that these items cover areas that may change once but not gradually over time (i.e., once
someone has a place to live that they are ok with they are not likely to have this progress any
more).
One potential way to improve the sensitivity to change of the URS would be to remove
these items; however, if the inability of these items to detect changes that are significantly
different from no change is due to a lack of emphasis in these recovery areas in consumer
treatment removing these items would only serve to further take attention away from these
recovery areas deemed important by consumers. For this reason, further inquiry is needed in
order to ascertain the likely cause of the failure of these items to detect changes in consumers
before a final decision can be made about whether to remove the items from the measure.
Validity for change. In addition to requiring an evaluative measure such as the URS to
be demonstrated as being sensitive to change, it is also important to examine the validity of the
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changes that are measured by the instrument. For this reason the consumer treatment trajectories
as measured by the URS were compared with consumer treatment trajectories as measured by the
OQ-45. When HLM was used to compare consumer treatment trajectories over time between the
two measures, they were found to track change in a similar way overall. When they were
examined among different classifications of consumers, the measures were again found to be
mostly similar. In cases where the slopes of the two measures were found to be significantly
different there was no difference in the directionality of the slopes (positive vs. negative) and the
URS was consistently found to have a shallower slope in such situations, indicating that the URS
may not be as sensitive to certain types of changes as the OQ-45.
The observed similarities between consumer changes as measured by the URS and
consumer changes as measured by the OQ-45 provide evidence for the URS’s validity for change
in the sense that recovery and distress are theoretically related to one another. Further, the
observed differences may suggest that the two domains are somewhat different in terms of the
way consumers change throughout the course of treatment. One possible explanation for the
observed differences between the two measures could be that consumer changes in the domain of
recovery occur more gradually than consumer changes in the domain of distress. For this reason
it may be more useful to administer recovery instruments, such as the URS, less frequently than
distress instruments, such as the OQ-45. Such an approach may also be practically beneficial so
as not to overly burden consumers with the frequent administration of too many outcome
measures throughout the course of their treatment.
Another area to explore in terms of examining an evaluative measure’s validity for
measuring change is whether the measure is able to detect clinically significant changes in
consumers over time (Jacobson, Truax, and Kazdin, 1992). The ability of the URS to detect
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clinically significant changes was examined by calculating an RCI for the measure and then
comparing this with the established RCI of the OQ-45 (Jacobson et al., 1992). Calculating an
RCI for the URS allowed us to examine whether consumers were making observable changes
that show clinically useful movement from a clinical population towards a non-clinical
population. In other words, it allowed us to explore whether the URS might be able to detect
changes in consumers that might be useful to clinicians that are attempting to determine the
efficacy of treatment. Utilizing the RCI, the URS identified 12% of consumers as recovered
(scoring within a range that is most likely to be in a non-clinical population), 77% of consumers
as showing no change, 5% of consumers as improved (moving significantly towards scores that
are likely to fall in a non-clinical population), and 6% of consumers as deteriorated (moving
significantly away from scores that are likely to fall within a non-clinical population).
The RCI classifications observed among consumers by the URS were then compared
with RCI classifications made by the OQ-45. In terms of change metrics the two measures
appear to be capturing somewhat different phenomena. When compared, the URS identified the
proportion of consumers in the same category as the OQ-45 58% of the time. However, when
broken down into individual groups the URS change categorizations were equal to the OQ-45 to
a much lesser extent with the URS identifying only 42% of the consumers classified as recovered
by the OQ-45 , 12% of the consumers classified as improved by the OQ-45, and 23% of the
consumers classified as deteriorated by the OQ-45. In all cases, with the exception of the no
change classification, the URS identified fewer consumers in each category than the OQ-45.
This fits with the finding that recovery as measured by the URS may be less sensitive to clinical
changes than distress as measured by the OQ-45. These results provide further evidence that
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distress measured during the course of clinical treatment changes more drastically than recovery.
For this reason, the URS may be most useful as an occasional measure of treatment outcome.
Clinical Implications
It is important to discuss several possible clinical implications of the results of this study.
The first is that initial evidence for the reliability, validity, sensitivity to change, and validity for
change suggest that the URS may be a useful instrument for clinicians and community mental
health programs which are seeking to measure recovery among consumers over time. Given the
results of the study, the URS appears to be most useful as an occasional evaluative measure of
recovery. In other words, since changes in recovery as measured by the URS appear to be less
drastic, it is likely that the URS would most likely be useful as an occasional evaluative measure
(i.e., to be administered every month rather than every clinical visit or prior to case conferences
etc.).
The second implication is that the strong inverse relationship observed between recovery
and distress is encouraging for community mental health centers that may be implementing
recovery-oriented interventions. This relationship suggests that the implementations of
recovery-oriented interventions are unlikely to detract from treatment efforts that are aimed at
reducing consumer symptoms or distress. Further the strength of the relationship between the
two measures may even suggest that recovery-oriented interventions may bolster consumer gains
in distress reduction. It is important to note that, since this study was not experimental, further
inquiry is needed in order to fully explore the nature of the observed relationship between
recovery and consumer distress.
The third implication is that the strong relationship between the quality of life items from
the OQ-45 and the URS also provides evidence for the potential relationship between recovery
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and well-being as it has been discussed in the positive psychology literature. For this reason, it
might be helpful for clinicians to look towards positive psychology research, particularly in areas
of engagement, reported well-being, and social relationships, as a way of developing and
implementing recovery oriented interventions.

Limitations
In order for an evaluative measure to be valid for measuring changes in consumers over
time it must also measure stability in consumers who are not receiving treatment when compared
to consumers who are. For this reason, one of the major remaining questions regarding the
validity of the URS is test-retest reliability. A high test-retest reliability estimate observed in a
group of consumers not receiving treatment would provide evidence that the URS is actually
detecting changes that are the result of mental health treatment. Further, multiple
administrations given to a group of consumers not receiving treatment could also be compared
against consumers receiving treatment to further explore whether the URS as a measure and its
individual items are sensitive to change over time. This study compared the URS and the
individual items on the URS to zero; however, comparing it to a sample of individuals not in
treatment would provide better evidence for the sensitivity of the URS for change because we
know that even without treatment consumers may show a small amount of improvement over
time (Aneshensel, Estrada, Hansell, & Clark, 1987; Bromet, Dunn, Connell, Dew, & Schulberg,
1986; Durham, Burlingame, & Lambert, 1998; Henderson, Byrne, & Duncan-Jones, 1981; Jorm,
Duncan-Jones, & Scott, 1989).
An additional limitation was that consumers were not given the URS at intake. Because
of this we were unable to examine consumer treatment trajectories that started at intake. We
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were able to look at consumers beginning treatment in comparison to the OQ-45, but most often
these consumers were not given the URS until their second or third session. Examining a group
of consumers taking the URS at intake and then tracking them throughout treatment might give
us not only a more clear picture of recovery’s longitudinal relationship to distress, but also might
allow us to examine any time differences between the two (e.g., perhaps a certain level of
distress reduction is required before change in recovery can be observed).
It is also important to note that, since this study was not experimental, no direct
conclusions can be made about causality in terms of recovery or the relationship between
recovery-oriented interventions and the reduction of consumer distress due to treatment. For this
reason it is important to note that that the observed relationship between these two measures
could be related to other unspecified variables. The results of this study do, however, provide a
rationale for conducting an experimental study comparing consumers receiving recoveryoriented interventions with consumers that are receiving other treatments.
Lastly, it is also important to note that while the URS was developed utilizing consumer
feedback and focus groups, it was not constructed utilizing a large pool of items. This is
important to note because it is possible that utilizing a large pool of items in its construction
would have provided a more conservative approach to insuring that the domain of recovery was
adequately captured by the measure. For this reason, further exploration is needed in comparing
the URS with other measures of recovery that are thought to cover multiple domains of recovery
such as the RAS (Corrigan et al., 1999).
Future Directions
In order to further bolster the construct validity of the URS it may be helpful to explore
whether there is evidence for the temporal stability of the URS. In other words, a test-retest
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reliability estimate would further add to the evidence as to whether the URS is a useful tool for
measuring consumer changes according to the construct of recovery. Obtaining multiple
administrations from a group of consumers not receiving treatment would also provide a means
for exploring whether the changes measured by the URS are actually the result of consumers
receiving mental health treatment.
In addition, in order to further provide evidence for the construct validity of the URS, it
would be helpful to compare the URS with other established recovery instruments, such as the
RAS or the STORI (Andresen et al., 2006; Corrigan et al., 1999). While these instruments have
not been explored in terms of their ability to detect change, they provide additional ways of
measuring the construct of recovery that could prove useful in examining whether the URS
adequately captures the construct of recovery.
As previously mentioned, a direct comparison study is needed to explore differences in
outcomes between consumers receiving treatments based on the recovery model and consumers
that are receiving other types of treatments. This would allow for a more specific exploration of
the strong inverse relationship between recovery and distress that was observed in this study.
Further exploring the specifics of this relationship would allow clinicians to gain a better
understanding of the types of interventions that contribute to both an increase in consumer
recovery and a decrease in consumer distress.
The strong relationship between the URS and the quality of life items on the OQ-45 also
provides initial evidence that there may be a relationship between recovery and well-being. In
order to further explore this observed relationship it would be necessary to compare a recovery
measure such as the URS with a gold standard measure of well-being. This comparison would
allow for further exploration of the relationship between recovery and well-being. In addition, a
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controlled study that utilizes positive psychology interventions would be able to explore more
specifically whether well-being oriented interventions lead to an increase in consumer recovery.
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Appendix A
Utah Recovery Indicators

Name:_________________ Male:  Female:

ID#:_________________ Date of Birth:
/
/___

Today’s Date:

/

/___

Instructions: The following questions ask about how you feel about working together in
a group. Please read each question carefully, and then mark the box that best describes
HOW MUCH OF THE TIME YOU HAVE FELT THIS WAY DURING THE PAST
MONTH (30 days). There are no right or wrong answers, so please be as honest as you
can.
Never

Rarely

Sometimes

Frequently

Almost
Always

1. I have hope for the future.

1

2

3

4

5

2. I have meaningful work,
volunteer work or activities
in my life.

1

2

3

4

5

3. Most days I get to do
something I enjoy.

1

2

3

4

5

4. I have a place to live and
it’s ok.
5. My life has meaning.

1

2

3

4

5

1

2

3

4

5

6. I have people/friends that
I can turn to.

1

2

3

4

5

7. I am connected to my
community.
8. I am in charge of my own
life and recovery.

1

2

3

4

5

1

2

3

4

5

9. I have goals for my
future.

1

2

3

4

5

10. I have meaningful
relationships.

1

2

3

4

5

Total Score
Developed by NAMI-Utah in collaboration with Brigham Young University

Do not
mark
below
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Appendix B: Outcome Questionnaire (OQ -45.2)

Instructions: Looking back over the last week, including today,
help us understand how you have been feeling. Read each item
carefully and mark the box under the category which best describes
your current situation. For this questionnaire, work is defined as
employment, school, housework, volunteer work, and so forth.
Please do not make any marks in the shaded areas.

Session #

Date

/

/

12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.

I get along well with others.
4
I tire quickly.................................................................................................  0
I feel no interest in things.
0
I feel stressed at work/school. ......................................................................  0
I blame myself for things.
0
I feel irritated. ..............................................................................................  0
I feel unhappy in my marriage/significant relationship.
0
I have thoughts of ending my life. ...............................................................  0
I feel weak.
0
I feel fearful. ................................................................................................  0
After heavy drinking, I need a drink the next morning to get
0
going. (If you do not drink, mark “never”)
I find my work/school satisfying. ................................................................  4
I am a happy person.
4
I work/study too much. ................................................................................  0
I feel worthless.
0
I am concerned about family troubles. .........................................................  0
I have an unfulfilling sex life.
0
I feel lonely. .................................................................................................  0
I have frequent arguments.
0
I feel loved and wanted. ...............................................................................  4
I enjoy my spare time.
4
I have difficulty concentrating. ....................................................................  0
I feel hopeless about the future.
0
I like myself. ................................................................................................  4
Disturbing thoughts come into my mind that I cannot get rid of.
0
I feel annoyed by people who criticize my drinking (or drug use). ..............  0
(If not applicable, mark “never”)
I have an upset stomach.
0
I am not working/studying as well as I used to. ...........................................  0
My heart pounds too much.
0
I have trouble getting along with friends and close acquaintances...............  0
I am satisfied with my life.
4
I have trouble at work/school because of drinking or drug use. ...................  0
(If not applicable, mark “never”)
I feel that something bad is going to happen.
0
I have sore muscles. .....................................................................................  0
I feel afraid of open spaces, of driving, or being on buses,
0
subways, and so forth.
I feel nervous. ..............................................................................................  0
I feel my love relationships are full and complete.
4
I feel that I am not doing well at work/school. .............................................  0
I have too many disagreements at work/school.
0
I feel something is wrong with my mind......................................................  0
I have trouble falling asleep or staying asleep.
0
I feel blue. ....................................................................................................  0
I am satisfied with my relationships with others.
4
I feel angry enough at work/school to do something I might regret. ............  0
I have headaches.
0

Developed by Michael J. Lambert, Ph.D. and Gary M. Burlingame, Ph.D.
© Copyright 1996 OQ Measures LLC.
All Rights Reserved. License Required For All Uses.

For More Information Contact:

yrs.
Sex

M

ID#
Never

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.

Age:

Name:

Almost
Rarely Sometimes Frequently Always

3
1
1
1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2
2
2
2

1
3
3
3
3
3
3
3
3
3
3

0
4
4
4
4
4
4
4
4
4
4

3
3
1
1
1
1
1
1
3
3
1
1
3
1
1

2
2
2
2
2
2
2
2
2
2
2
2
2
2
2

1
1
3
3
3
3
3
3
1
1
3
3
1
3
3

0
0
4
4
4
4
4
4
0
0
4
4
0
4
4

1
1
1
1
3
1

2
2
2
2
2
2

3
3
3
3
1
3

4
4
4
4
0
4

1
1
1

2
2
2

3
3
3

4
4
4

1
3
1
1
1
1
1
3
1
1

2
2
2
2
2
2
2
2
2
2

3
1
3
3
3
3
3
1
3
3

4
0
4
4
4
4
4
0
4
4

OQ MEASURES LLC
E-MAIL: INFO@OQMEASURES.COM
WEB: WWW.OQMEASURES.COM
TOLL-FREE: 1-888-MH SCORE, (1-888-647-2673)
FAX: 801-990-4236

SD

F

IR

+

Total=

SR

+
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Appendix C: Individual item HLM analysis graphs
URS total score compared to zero
1

0

1

Interaction

2

Zero

3

URS total

4

Standard
Estimate
Error
DF
0.07654
0.01304

5

1093

T value

5.87

pr>t

0.0001

URS item 1 compared to zero
1

0

1

Interaction

2

Zero

3

Item 1

Standard
Estimate
Error
DF
0.04967
0.01561

4

5

1016

T value

3.18

pr>t

0.0015
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URS item 2 compared to zero
1

0

1

Interaction

2

Zero

3

Item2

4

Standard
Estimate
Error
DF
0.06763
0.01678

5

1075

T value

4.03

pr>t

0.0001

URS item 3 compared to zero
1

0

1

Interaction

2

Zero

3

Item 3

Standard
Estimate
Error
DF
0.07075
0.01584

4

5

1008

T value

4.47

pr>t

0.0001
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URS item 4 compared to zero
1

0

1

Interaction

2

Zero

3

Item 4

4

Standard
Estimate
Error
DF
0.01913
0.01643

5

1177

T value

1.16

pr>t

0.2446

URS item 5 compared to zero
1

0

1

Interaction

2

Zero

3

Item 5

Standard
Estimate
Error
DF
0.0747
0.01447

4

5

916

T value

5.16

pr>t

0.0001
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URS item 6 compared to zero
1

0

1

Interaction

2

Zero

3

Item 6

4

Standard
Estimate
Error
DF
0.02135
0.01569

5

1044

T value

1.36

pr>t

0.174

URS item 7 compared to zero
1

0

1

Interaction

2

Zero

3

Item 7

Standard
Estimate
Error
DF
0.075
0.01502

4

5

1053

T value

4.99

pr>t

0.0001
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URS item 8 compared to zero
1

0

1

Interaction

2

Zero

3

Item 8

4

Standard
Estimate
Error
DF
0.07862
0.01721

5

1121

T value

4.57

pr>t

0.0001

URS item 9 compared to zero
1

0

1

Interaction

2

Zero

3

Standard
Estimate
Error
0.05082 0.01459

Item 9

DF

4

5

941

T value

3.48

pr>t

0.0005
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URS item 10 compared to zero
1

0

1

Interaction

2

Zero

3

Item 10

Standard
Estimate
Error
DF
0.02817
0.1597

4

5

1161

T value

1.76

pr>t

0.078
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Appendix D: URS and OQ-45 HLM Treatment Trajectory Comparisons Over Time.
OQ-45 and URS total scores
0

1

2

-1

3

Total Score OQ-45

4

Total Score URS

Standard
Estimate
Error
DF
0.001246
0.01384

Interaction

5

9080

T value

0.09

pr>t

0.9282

Consumers categorized by the OQ-45 as distressed
0.5

1

-0.5

Interaction

2

Distressed OQ-45

3

4

5

Distressed URS

Standard
Estimate
Error
DF
0.04419
0.01615

5774

T value

2.74

pr>t

0.0062
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Consumers categorized by the OQ-45 as starting treatment clinically distressed and improved
over time.
0

1

2

3

4

5

-1

-2

Distressed Improved OQ-45

Distressed Improved URS

Standard
Estimate
Error
DF
0.1482
0.03642

Interaction

1156

T value

4.07

pr>t

0.0001

Consumers categorized by the OQ-45 as starting treatment in the clinically distressed range and
moving into the recovered range.
0

1

2

3

4

5

-1

-2

Interaction

Distressed Recovered OQ-45

Distressed Recovered URS

Standard
Estimate
Error
DF
0.192
0.04578

974

T value

pr>t
4.19 <.0001
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Consumers categorized by the OQ-45 as starting treatment in the clinically distressed range and
then exhibiting no change over time.
1

0

1

Interaction

2

Distressed No change OQ-45

3

4

5

Distressed No change URS

Standard
Estimate
Error
DF
-0.02235
0.01876

3193

T value

-1.19

pr>t

0.2337

Consumers categorized by the OQ-45 as starting treatment in the distressed range and then
deteriorating over time.
3
2
1
0

1

2

3

Distressed Deteriorated OQ-45

Interaction

4

5

Distressed Deteriorated URS

Standard
Estimate
Error
DF
-0.06672
0.05423

107

T value

-1.23

pr>t

0.2213
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Consumers categorized by the OQ-45 as starting treatment in the not distressed range.
0

1

-1

2

3

Not distressed OQ-45

4

Not distressed URS

Standard
Estimate
Error
DF
-0.06148
0.02481

Interaction

5

415

T value

-2.48

pr>t

0.0136

Consumers categorized by the OQ-45 as starting treatment in the not distressed range and then
deteriorated over time.
3
2
1
0
-1

1

2

3

4

5

Not Distressed Deteriorated OQ-45
Not Distressed Deteriorated URS

Interaction

Standard
Estimate
Error
DF
-0.2726
0.05868

831

T value

-4.65

pr>t

0.001
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Consumers categorized by the OQ-45 as starting treatment in the not distressed range and then
improved over time.
0
-1

1

2

3

4

5

-2
-3
-4

Not distressed improved OQ-45
Not distressed improved URS

Standard
Estimate
Error
DF
0.1672
0.06052

Interaction

103

T value

2.76

pr>t

0.0068

Consumers categorized by the OQ-45 as starting treatment in the not distressed range and then
did not change over time.
0

-1

1

2

3

4

5

Not distressed No change OQ-45
Not distressed No change URS

Interaction

Standard
Estimate
Error
DF
-0.04758
0.02743

300

T value

-1.73

pr>t

0.0838
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Consumers beginning their first episode of treatment.
0

-1

Interaction

1

2

3

Beginning treatment OQ-45
Estimate
0.04011

Standard
Error
0.02619

4

5

Beginning treatment URS

DF

T value
2386

pr>t
1.53

0.1258
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Appendix E: The SAMHSA Fundamental Components of Recovery
Recovery
Components

Definition

Self-Direction

Consumers lead, control, exercise choice over, and determine their own path of recovery by
optimizing autonomy, independence, and control of resources to achieve a self-determined
life. By definition, the recovery process must be self-directed by the individual, who defines
his or her own life goals and designs a unique path towards those goals.

Individualized
and PersonCentered

Consumers lead, control, exercise choice over, and determine their own path of recovery by
optimizing autonomy, independence, and control of resources to achieve a self-determined
life. By definition, the recovery process must be self-directed by the individual, who defines
his or her own life goals and designs a unique path towards those goals.

Empowerment

Consumers have the authority to choose from a range of options and to participate in all
decisions—including the allocation of resources—that will affect their lives, and are
educated and supported in so doing. They have the ability to join with other consumers to
collectively and effectively speak for themselves about their needs, wants, desires, and
aspirations. Through empowerment, an individual gains control of his or her own destiny
and influences the organizational and societal structures in his or her life.

Responsibility

Consumers have a personal responsibility for their own self-care and journeys of recovery.
Taking steps towards their goals may require great courage. Consumers must strive to
understand and give meaning to their experiences and identify coping strategies and healing
processes to promote their own wellness.

Strengths-Based

Recovery focuses on valuing and building on the multiple capacities, resiliencies, talents,
coping abilities, and inherent worth of individuals. By building on these strengths,
consumers leave stymied life roles behind and engage in new life roles (e.g., partner,
caregiver, friend, student, employee). The process of recovery moves forward through
interaction with others in supportive, trust-based relationships.

Hope

Recovery provides the essential and motivating message of a better future— that people can
and do overcome the barriers and obstacles that confront them. Hope is internalized; but can
be fostered by peers, families, friends, providers, and others. Hope is the catalyst of the
recovery process. Mental health recovery not only benefits individuals with mental health
disabilities by focusing on their abilities to live, work, learn, and fully participate in our
society, but also enriches the texture of American community life. America reaps the
benefits of the contributions individuals with mental disabilities can make, ultimately
becoming a stronger and healthier Nation.

Peer Support

Mutual support—including the sharing of experiential knowledge and skills and social
learning—plays an invaluable role in recovery. Consumers encourage and engage other
consumers in recovery and provide each other with a sense of belonging, supportive
relationships, valued roles, and community.

Respect

Community, systems, and societal acceptance and appreciation of consumers —including
protecting their rights and eliminating discrimination and stigma—are crucial in achieving
recovery. Self-acceptance and regaining belief in one’s self are particularly vital. Respect
ensures the inclusion and full participation of consumers in all aspects of their lives.
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Recovery
Components

Definition

Holistic

Recovery encompasses an individual’s whole life, including mind, body, spirit, and
community. Recovery embraces all aspects of life, including housing, employment,
education, mental health and healthcare treatment and services, complementary and
naturalistic services, addictions treatment, spirituality, creativity, social networks,
community participation, and family supports as determined by the person. Families,
providers, organizations, systems, communities, and society play crucial roles in creating
and maintaining meaningful opportunities for consumer access to these supports.

Non-Linear

Recovery is not a step-by-step process but one based on continual growth, occasional
setbacks, and learning from experience. Recovery begins with an initial stage of awareness
in which a person recognizes that positive change is possible. This awareness enables the
consumer to move on to fully engage in the work of recovery.
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Appendix F: URS Telephone Survey Script
Instructions: Read all of the instructions in quotation marks verbatim aloud to the participants,
and record their answers in the spaces provided.
“Before I start, are you 18 or older” yes/no (circle one)
If the responded responds no, thank them for their time, and inform them that we are only able to
survey individuals above the age of 18. Read them the final statement of the informed consent
form and proceed to the next call.
“ I am going to start by asking you a couple of demographic questions.”
1. “What is your current age?” ____
2. “What is your gender?” Male/female (circle one)
3. “What is your ethnicity? _____________
4. “Are you currently receiving therapeutic or pharmacological treatment for mental illness?”
_____
“Looking back over the last week, including today, please let us know how you have been
feeling in relation to these questions over the last week, including today. Please rank the
following statements on a scale of 0 to 4 with 0 representing never, 1 representing rarely, 2
representing sometimes, 3 representing frequently, and 4 representing almost always.”
Proceed to read aloud each question followed by reading each possible response allowed (e.g. “I
have hope for the future, 0 – never, 1 – rarely, 2 – sometimes, 3 – frequently, 4 – almost always).
1. I have hope for the future.
0
1
Never
Rarely

2
Sometimes

3
Frequently

2. I have meaningful work, volunteer, work or activities in my life.
0
1
2
3
Never

Rarely

Sometimes

3. Most days I get to do something that I enjoy.
0
1
2
Never

Rarely

4. I have a place to live and it’s ok.
0
1
Never
Rarely

Frequently

3

4
Almost Always

4
Almost Always

4

Sometimes

Frequently

Almost Always

2
Sometimes

3
Frequently

4
Almost Always
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5. My life has meaning.
0
1
Never

Rarely

2

3

4

Sometimes

Frequently

Almost Always

6. I have people/friends that I can turn to.
0
1
2
Never
Rarely
Sometimes

3
Frequently

4
Almost Always

7. I am connected to my community.
0
1
Never

Rarely

2

3

4

Sometimes

Frequently

Almost Always

8. I am in charge of my own life and recovery.
0
1
2
Never
Rarely
Sometimes

3
Frequently

4
Almost Always

9. I have goals for my future.
0
1
Never
Rarely

3
Frequently

4
Almost Always

10. I have meaningful relationships.
0
1
Never

Rarely

2
Sometimes
2
Sometimes

3
Frequently

4
Almost Always

Upon completion of the last question say the following:
“Thank you for participating in our research survey today. Would you be willing to fill this
survey out one more time in 2 to 4 weeks online?”
If the participant says yes, say the following:
“May we have an email address that we can use to send you a link to the survey?”
___________________
If the participant says no, proceed with the closing statement from the informed consent script.
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Appendix G: URS Total Score Correlations with Individual OQ-45 Items.
OQ-45 Items

r

n

2. I tire quickly.

-.425

8487

1. I get along well with others.
3. I feel no interest in things.

4. I feel stressed at work/school
5. I blame myself for things.
6. I feel irritated.

7. I feel unhappy in my marriage/significant relationship.
8. I have thoughts of ending my life.
9. I feel weak.

10. I feel fearful.

-.550
-.612
-.332
-.488
-.491
-.397
-.506
-.504
-.510

11. After heavy drinking, I need a drink the next morning to get going. -.066
12. I find my work/school satisfying.

-.594

14. I work/study too much.

.096

13. I am a happy person.
15. I feel worthless.

16. I am concerned about family troubles.
17. I have an unfulfilling sex life.
18. I feel lonely.

19. I have frequent arguments.
20. I feel loved and wanted.

-.709
-.654
-.345
-.383
-.582
-.377
-.702

8477
8474
8425
8490
8486
8372
8485
8484
8472
8452
8374
8483
8442
8477
8486
8384
8488
8484
8491
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21. I enjoy my spare time.

-.683

8483

23. I feel hopeless about the future.

-.669

8488

22. I have difficulty concentrating.
24. I like myself.

25. Disturbing thoughts come into my mind that I cannot get rid of.

26. I feel annoyed by people who criticize my drinking (or drug use).
27. I have an upset stomach.

28. I am not working/studying as well as I used to.
29. My heart pounds too much.

30. I have trouble getting along with friends and close acquaintances.
31. I am satisfied with my life.

32. I have trouble at work/school because of drinking or drug use.
33. I feel that something bad is going to happen.
34. I have sore muscles.

-.489
-.706
-.475
-.094
-.372
-.370
-.428
-.495
-.744
-.065
-.539
-.355

35. I feel afraid of open spaces, of driving, or being on buses, subways, -.408
and so forth.

8487
8487
8486
8460
8325
8460
8485
8492
8501
8460
8380
8477
8483

36. I feel nervous.

-.486

8455

38. I feel that I am not doing well at work/school.

-.276

8433

37. I feel my love relationships are full and complete.
39. I have too many disagreements at work/school.
40. I feel something is wrong with my mind.

41. I have trouble falling asleep or staying asleep.

-.595
-.286
-.537
-.396

8456
8434
8483
8490
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42. I feel blue.

-.608

8495

44. I feel angry enough at work/school to do something I might

-.339

8453

43. I am satisfied with my relationships with others.
regret.

45. I have headaches.

-.892

-.329

8486

8489
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Appendix H: Journal Article
Running Head: MEASURING GROWTH

Measuring Growth: The Reliability and Validity of the Utah Recovery Scale
R. Jason Katzenbach, Robert Gleave, Gary Burlingame, & Dallas Jensen
Brigham Young University
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Abstract
Objective: An approach to recovery that focuses on helping consumers foster meaningful
relationships, independent living, and fulfilling work has been emphasized in the mental health
care community. In accordance, the Utah division of the National Alliance on Mental Illness
generated recovery indicators (URS) to track consumer treatment progress. This study explored
reliability and validity estimates for the URS and the relationship between distress and recovery.
Methods: Community URS data were used in conjunction with archival data from community
mental health centers. A clinical cutoff score and reliable change index for the URS were
calculated. In addition, URS data were compared to Outcome Questionnaire 45 data using
hierarchical linear modeling (HLM).
Results: Evidence supporting the reliability of the URS was found: α = 0.898 (n = 91). The
URS yielded a cutoff score of 31 and a reliable change index of 8. Analyses also indicated a
strong inverse relationship between the URS and the OQ-45 (r = -.75, n = 8,483). In addition,
HLM analyses found that the URS tracks consumer progress in a similarly to the OQ-45 (t = .09,
df = 9080, p = .9282, n = 1954). Subsequent HLM analyses found the URS to be less sensitive
than the OQ-45 to consumer changes.
Conclusions: The evidence supports the reliability and validity of the URS’s ability to track
recovery. The results support the use of the URS as an occasional measure to track consumer
treatment response and suggest a strong relationship between recovery and reduction in
consumer distress.
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Measuring Growth: Reliability and Validity of the Utah Recovery Scale
In 2005, the Substance Abuse and Mental Health Services Administration (SAMHSA)
introduced an agenda to change mental health care delivery in the United States. The agenda
includes strategies for improving mental health services by implementing evidence-based
practices, focusing on recovery, and making treatment consumer/family driven (SAMHSA,
2005). Central to these strategies is the idea that recovery from mental illness is not only
possible, but also the expected outcome of effective treatment.
SAMHSA’s agenda focuses on a broader definition of recovery that is not limited to
symptom amelioration. According to this newer definition, recovery happens when mental health
consumers are able to function in society through obtaining meaningful work, fulfilling
relationships and independent living (Davidson, et al., 2005; Jacobson, 2004). Recovery in this
sense also involves the acquisition of positive coping skills, the restoration of a sense of self, and
the pursuit of purposeful living (O’Connor & Delaney, 2007). In addition, recovery from this
perspective is thought to relate not only to a reduction in distress but also to an increase in wellbeing as it has been explored in the positive psychology literature (Anthony 2003; Resnick &
Rosenheck 2006). From this perspective, the progress in recovery is assessed collaboratively by
the consumer, the care provider, and potentially the consumer’s family (Frese, Stanley, Kress, &
Vogel-Scibilia, 2001; Jacobson, 2004).
This broader approach to recovery has garnered a large amount of consumer support and
has begun to affect mental health treatment policy. Despite the ability of this movement to effect
change, very little testing has been done as to whether the implementation of this recovery
paradigm is beneficial for consumers. The research that has been done has typically relied
strictly on the input of a few consumers in order to shape how recovery is measured, rather than
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incorporating a clear definition of recovery into measure creation. Furthermore, no recovery
measures have been examined based on their ability to track consumer changes over time.
In order to more clearly define recovery SAMHSA organized a panel of mental health
care consumers, family members, providers, advocates, researchers, academicians, managed care
representatives, and accreditation organization representatives which together constructed a
consensus definition of the recovery model. The resulting consensus statement comprises 10
components that define recovery (SAMHSA, 2006). SAMHSA’s components specify a
direction for mental health service providers to steer towards in terms of recovery.
In an effort to measure SAMHSA’s 10 fundamental recovery components, the Utah
division of the National Alliance on Mentally Illness (NAMI-Utah) conducted consumer focus
groups in order to develop questions that could assess recovery based on SAMHSA’s model.
The focus groups developed 10 questions to serve as indicators of recovery. The resulting 10
recovery indicators were labeled the Utah Recovery Scale (URS).
This study examined the psychometric validity of the URS. In addition it also explored
the relationship between recovery as measured by the URS and reported consumer distress levels
as well as reported quality of life.
Methods
It was necessary to examine the URS in two phases. The first phase of the study was to
collect community data for the URS in order to obtain URS data from a non-clinical sample.
The next phase of the study examined archival community mental health URS and Outcome
Questionnaire 45 (OQ-45) data. Institutional review board approval was obtained from the
Brigham Young University IRB for both phases of the study.
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Phase 1
Phase 1 of this study was to collect community data from individuals that were not
receiving mental health treatment in order to establish a comparison sample to contrast with
individuals receiving treatment. These data were collected in October 2009.
Participants. Participants were selected randomly from a local phone book. Trained
research assistants contacted participants via telephone and administered the survey according to
an administration script. A total of 91 participants were sampled including 53 women and 38
men. Participant ages ranged from 18 to 86 with the average age being 44. Data were not
collected for individuals under the age of 18. Demographically, 84 participants identified
themselves as Caucasian, 2 as African American, 2 as Asian, 1 as Polynesian, 1 as Latino, and 1
as Mixed Race. After complete description of the study to the participants, informed consent
was obtained. Sampled participants that indicated that they were currently receiving some form
of mental health treatment were excluded from this study.
Instruments.
The Utah Recovery Scale (URS). The Utah Recovery Scale (URS) was derived from a
series of consumer focus groups conducted by the Utah division of the National Alliance on
Mentally Illness (NAMI-Utah) in order to construct questions based on SAMHSA’s fundamental
components of recovery. The focus groups resulted in 10 questions based on SAMHSA’s
recovery components (SAMHSA, 2005). The URS is scored using a 5-point scale (0= never 1 =
rarely, 2 = sometimes, 3= frequently, 4 = almost always), which yields a possible range of scores
from 0 to 50.
The URS has no developed reliability or validity statistics. Initial criterion validity for the
measure, however, was investigated using additional consumer focus groups that pilot tested the
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measure. Participants for three focus groups were selected from three community mental health
centers. Two of the focus groups consisted of consumers receiving inpatient treatment while one
focus group consisted of participants receiving outpatient treatment. Focus groups ranged from 5
to 15 participants, comprising of a total of 30 participants. The focus group participants, after
signing a consent form, were asked to take the URS, and then were asked questions about their
experience taking the survey. The focus group leader closely followed a discussion guide of
questions and asked follow-up questions when appropriate. The groups lasted between 35 and
50 minutes and the groups were digitally recorded for further analysis. The recordings were
reviewed in conjunction with notes from the focus groups and analyzed for emergent themes.
Response to the URS from the focus groups was, for the most part, positive. Almost all
of the consumers across the groups said that the questions addressed elements of recovery that
were important to them—something that they did not always feel other outcome measures they
had been exposed to had done.
Phase 2
Data. Consumer data for this study were taken from the archival records of community
mental health centers in Utah. Community mental health centers that receive state funding track
treatment progress using a variety of measurement tools including the Outcome Questionnaire 45
(OQ-45) and the URS. Consumer data are then databased and reported back to clinicians using
the OQ-45 analyst system that was developed and supported by OQ-45 Measures LLC. This
database provides outcome data for each consumer. Approximately 30,000 adults receive mental
health services from the state of Utah on a yearly basis. Outcome data from inpatient, residential,
and outpatient consumers were analyzed.
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Instruments. In addition to the URS this phase of the study also examined consumer
distress as measured by the OQ-45.
The Outcome Questionnaire-45 (OQ-45). The Outcome Questionnaire-45 (OQ-45) is an
instrument designed to measure consumer outcomes in therapeutic settings (Lambert et al.,
2004). The OQ-45 is a 45 item self-report questionnaire scored using a 5-point scale (0= never 1
= rarely, 2 = sometimes, 3= frequently, 4 = almost always) that yields a possible range of scores
from 0 to 180. High scores on the OQ-45 indicate more distress and as consumers improve
scores decrease. The OQ-45 has been validated across cultures using a variety of normal and
consumer populations (Lambert et al., 2004). It has become a gold standard for measuring
distress as it relates to treatment, and was recently found to be the 3rd most commonly used
measure of outcome in a survey by psychologists in clinical practice (Hatfield & Ogles, 2004).
The OQ-45 takes approximately 5-7 minutes to complete and is typically administered
prior to each treatment session. Concurrent validity is moderate to high (r = 0.50 - 0.85) when
correlated with measures most often used to assess psychotherapy outcome in clinical trials
(Lambert et al., 2004). Most importantly, the OQ-45 has been shown to be sensitive to changes
in consumers over short time periods, while remaining stable in untreated individuals
(Vermeersch, Lambert, & Burlingame, 2000 & Vermeersch et al., 2004). The OQ-45 has a
reported 3-week test-retest reliability value of r = .84 and a reported internal consistency of r =
.93 (Lambert et al., 2004). Reliable change indices (RCI) for the OQ-45 have been calculated
using formulas developed by Jacobson and Truax (1991). The RCI for the OQ-45 was calculated
to be 14 points using normative data from community non-consumers (N = 1353) and consumers
entering treatment (n = 1476), thus consumers who exhibit a 14 point positive or negative change
are found to have made reliable change. A clinical cutoff score of the OQ-45 was found to be
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63/64, thus when a consumer’s score drops under 64 they are thought to be functioning more like
non-consumers than typical consumer populations. When a consumer’s score has dropped by 14
points or more, and fallen under 64, then the consumer has met the criteria for clinically
significant change (Ellsworth et al., 2006).
In addition to the total score the OQ-45 has three subscales that measure quality of
interpersonal relations, social role functioning and symptom distress (Lambert, et al., 2004). The
Subjective Distress subscale is a 25-item scale that evaluates symptoms such as depression and
anxiety. The Interpersonal Relationship subscale consists of 11 items that attempt to assess
functioning in interpersonal relationships. The final subscale, Social Role consists of 9 items
that attempts to measure dysfunction in roles such as work and leisure life activities. The OQ-45
also contains several reverse scored quality of life items designed to measure things like quality
of relationships and overall life satisfaction
Statistical Analysis
Hierarchical linear modeling (HLM) was used to examine the longitudinal relationship
between the URS and the OQ-45. Research examining treatment trajectory growth curves is
ideally suited to the use of HLM that can be generated from consumer responses to outcome
measure items (Arnold, 1992). In addition, HLM accounts for missing data so that missing
participant data does not need to be thrown out because of the limitations of the model (Speer &
Greenbaum, 1995). The HLM analyses for this study were conducted using PROC MIXED in
SAS.
Results
To explore the reliability of the URS participants were randomly selected from the
community. After giving consent participants answered a few demographic questions and then
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the URS items over the phone. Six participants that indicated that they were currently receiving
some form of mental health treatment were excluded from this analysis. The overall URS
internal consistency estimate was high (α = 0.898, n = 91).
Next, archival consumer data from community mental health centers in the state of Utah
were used in order to explore the relationship between recovery and consumer distress using the
OQ-45. Initial analyses indicated a strong inverse relationship between the two measures (r = 0.75, n = 8,483). The strong inverse relationship indicates that consumers that scored higher on
recovery as measured by the URS scored lower on distress as measured by the OQ-45. In
addition, several individual items from the two measures had moderately strong negative
correlations (r < -.6) and are reported in Table 1. In addition, moderate to strong relationships
were also found between the URS and each of the OQ-45 subscales: Symptom Distress (-.711, n
= 7878), Social Role Functioning (-.576, n = 8,197), and Interpersonal Relations (-.746, n =
8162).
The OQ-45 contains several reverse scored quality of life items designed to measure things
like quality of relationships and overall life satisfaction. As with the rest of the OQ-45, higher
scores on these items are indicative of higher levels of distress. A composite score was created
from these items and then compared with the URS total score. A strong inverse relationship was
shown between the quality of life items (higher scores indicate higher levels of distress) and the
URS (higher scores indicate higher levels of recovery) (r=-.863, n= 8,216) (consumers with
missing scores on these particular items were excluded from this analysis).
Next, archival longitudinal consumer data from community mental health centers in Utah
were explored in order to assess the URS’s ability to detect changes among consumers. This
sample consisted of 1445 consumers that took the URS over several administrations ranging
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from 2 to 16 with the average number of administrations being 3.5. The first step in this process
was to calculate a cutoff point, or the point along the range of possible URS scores that best
separates the distribution of the non-consumer scores from the distribution of consumer scores.
The cutoff point between adjacent samples defines the point where it is statistically more likely
for a score to be in one, as opposed to the adjacent overlapping distribution (Jacobson et al.,
1984). The calculation is as follows:

Where SD1 is the standard deviation of the clinical (consumer) population, Mean2 is the mean of
the non-consumer population, SD2 is the standard deviation of the non-consumer population, and
Mean2 is the mean of the clinical (consumer) population. In order ensure homogeneity of the
consumer sample, consumers whose OQ-45 score fell below the clinical cutoff of 63 were
excluded from the analysis. Descriptive data for these two samples on the URS are reported in
Table 2.
Prior to calculating a cutoff point it was first necessary to ensure that both samples used in
the calculation were statistically distinct (Tingey et al., 1996). Distinctness of the samples was
determined using an independent samples t test and a “d” test. The samples met both criteria for
statistical distinctness. The independent samples t value of -27.841 (p<.05, df =95.577)
surpassed alpha of .05. In addition, the calculated “d” value surpassed the criterion of .5 further
indicating the distinctiveness of the two samples (d = 2.56). Once distinct samples were
statisically verified a cutoff point of 28.799 (28/29) was calculated.
The cutoff score enables the URS to function in distinguishing consumers from nonconsumers. Table 3 presents the acuracy with which the cutoff score classified respondents. The
sensitivity of .89 indicates that of actual consumers, 89% scored below the clinical cutoff score
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of 29 and 11% scored above. In other words, use of the cutoff score identified 89% of actual
consumers. The specificity of .95 indicates that of the actual non-consumers, 95% scored above
the cutoff score and 5% scored below. Thus the cutoff score identified 95% of actual nonconsumers. The overall accuracy of the cutoff score in predicting consumer versus nonconsumer status was 0.89 (hit rate). The positive predictive power (PPP) of .99 indicates that of
the cases the cutoff score predicted to be consumers, 99% of them were actual consumers. The
negative predicitve power (NPP) of .14 indicates that of the cases the cutoff score predicted to be
non-consumers, 14% of them were actual non-consumers. Note that whereas the test
characteristics of sensitivity, specificity, and hit rate are relativiely independent of prevalence of
the condition being tested, the characteristics of PPP and NPP are highly dependent upon
prevalence (Streiner, 2003). Thus the high PPP and low NPP are expected considering the large
proportion of consumers (98%) versus non-consumers (2%) in the sample producing these
indeces.
In addition to a cutoff score, a reliable change index (RCI) was also calculated for the
URS. The RCI is a way of determining whether changes observed on a measure are greater than
what would be attributed to measurement error (Tingey et al., 1996). The RCI is calculated by
multiplying the standard error of the difference by the point location on a distribution in order to
achieve a certain confidence interval. The RCI for the URS was calculated at the 95% confidence
level. In addition, the reliability coefficient used in the equation was Cronbach’s alpha
coefficient of .898 obtained from the community sample. The equation for calculating the RCI is
presented below:
95%𝑅𝐶𝐼 = 𝑆𝑑𝑖𝑓𝑓 = (4.095)(1.96) = 8.062 = 8/9
𝑆𝑑𝑖𝑓𝑓 = �2(𝑆𝐸 )2 = �2(2.896)2 = 4.095
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𝑆𝐸 = 𝑆𝐷𝑝 √1 − 𝛼 = 9.066√1 − 0.898 = 2.896

(1542 − 1)(8.983) + (1445 − 1)(9.1554)
(𝑛1 − 1)(𝑆𝐷12 ) + (𝑛2 − 1)(𝑆𝐷22 )
=�
= 9.066
(1542 + 1445 − 2)
(𝑛1 + 𝑛2 − 2)

𝑆𝐷𝑝 = �

where 95% RCI is the RCI value at the 95% confidence level, Sdiff is the standard error of the

difference, SE is the standard error of measurement, SDp is the pooled standard deviation for the
first and last score used in the calculation, α is the internal consistency reliability utilized for the
calculation, n1 is the sample size for the first administration, n2 is the sample size for the last
administration, SD1 is the standard deviation of the first administration of the URS, and SD2 is
the Standard deviation of the last administration of the URS. The calculated RCI for the URS
was 8.026 indicating that consumers who have changes greater than 8 points in their total URS
score have made clinically significant change.
The RCI and the cutoff score were used to determine consumer improvement,
deterioration, and stability. In addition, consumers that reached the clinical cutoff of score of
greater than 28 were considered recovered. Consumers whose first and last scores did not have a
corresponding OQ-45 score because of missing data were excluded from this analysis. The
results are presented in the table 5. Next consumers were compared based on their change status
as calculated by the URS with their change status as calculated by the OQ-45. The results are
presented in Table 5.
In order to investigate the URS’s sensitivity to consumer changes over time the
consumers’ total scores and individual item scores were compared against zero (or no change).
HLM was used for this analysis because there are multiple waves of data among consumers with
differing numbers of administrations per consumer. Results of the initial data analysis indicated
that the URS total score and all 10 items met the first criterion for change sensitivity in that they
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demonstrated change in the theoretically proposed direction (i.e., consumers improved over time
as illustrated by a positive slope). Of these 10 items, 7 demonstrated a slope that was
significantly different from zero. The results are presented in Table 6.
Next, treatment trajectories measured by the URS were compared to treatment
trajectories measured by the OQ-45 using HLM. Prior to conducting these statistical analyses,
reverse scoring procedures were performed on URS data so that lower scores indicated
improvement similarly to the OQ-45. In addition, scores from the two tests were standardized
using Z scores so that both measures were on an equal scale. Results of the initial data analysis
indicated that the URS tracked change in the theoretically proposed direction (i.e., consumers
improved over time at a similar rate as measured by the OQ-45). In groups in which the slopes
of the two measures were statistically different the OQ-45 had a steeper slope suggesting that the
URS may not be as sensitive to certain types of changes in consumers. The results are presented
in Table 7.
Discussion
This study examined the psychometric validity of the URS. The URS was examined in
several psychometric categories including reliability, validity, sensitivity to change, and validity
for change. First, data were collected from a randomly sampled community population in order
to explore the reliability of the URS. Next, archival URS data collected from mental health
consumers in the state of Utah were also examined in order to answer questions regarding the
validity of the measure as well as the measure’s ability to detect clinically meaningful changes
among consumers.
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Prior to examining the psychometric validity of the URS, its reliability was first
examined. The obtained internal consistency estimate of α = 0.898 (n = 91) provides initial
evidence for the reliability of the URS.
Next, the criterion related validity of the URS was explored. Theoretically, a high score
on a recovery measure should have a moderate negative correlation with consumer distress.
Initial analyses indicate a strong inverse relationship between the two measures (r = -0.75, n =
8,483). This strong relationship provides evidence that consumers with higher recovery scores
are likely to have lower distress scores and vice versa. This finding provides some evidence for
the validity of the URS because recovery and distress are thought to be inversely related. This
conclusion is also supported by the URS’s strong relationship to the Symptom Distress subscale
of the OQ-45 (r = -.711, n = 7878). This stronger than expected relationship may also provide
evidence that the constructs of recovery and consumer distress actually overlap to an extent that
measuring recovery separately may be unnecessary. In addition, this finding provides initial
evidence that consumers receiving recovery-focused treatments are more likely to show
improvement in reduction of distress. Since this relationship is correlational more research is
needed in order to further explore this possibility. In addition, the URS’s demonstrated strong
relationship to the OQ-45 subscale of Interpersonal Relations (r=-.746, n=8162) and moderate
relationship to the OQ-45 subscale of Social Role (r=-.576, n=8197) provide further evidence for
the construct validity for the URS by demonstrating that consumers exhibiting higher levels of
recovery exhibit lower levels of relationship problems, and lower levels of role dissatisfaction.
In addition, a strong inverse relationship was shown between the reverse scored quality of
life items (higher scores indicate higher levels of distress) and the URS (higher scores indicate
higher levels of recovery) (r=-.863, n= 8,216). This strong relationship indicates that recovery
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seems to be highly related to consumer quality of life as expected. This strong relationship
provides initial evidence for the possible link between recovery and factors that may contribute
to well being.
Sensitivity and Specificity
Next, the URS’s ability to differentiate between clinical and non-clinical populations was
examined. The URS was generally accurate in both its identification of actual consumers
(sensitivity = .89) as well as its identification of actual non-consumers (specificity = .95). The
ability of the URS to identify both consumers and non-consumers accurately suggests its cutoff
score could be useful for identifying when consumers move from a clinical population to a nonclinical population during treatment
Next, the URS’s sensitivity to changes among consumers in treatment was explored. In
order to investigate the URS’s ability to detect change the URS was compared against 0 or no
change. The URS total score was demonstrated to be significantly different from zero when
tracking consumers in treatment over time. The observed changes also occurred in the
theoretically specified direction (i.e., consumers in treatment improved). In terms of the
individual items, all 10 of items demonstrated change in the theoretically specified direction;
however, only 7 of the ten items demonstrated a rate of change that was statistically significant
when compared to zero. This finding provides evidence that the URS as a whole as well as 7 of
the 10 items are able to detect changes in consumers in treatment over time. The three items that
did not detect significant change when compared to zero were “I have a place to live and it’s
ok,”; “I have people/friends I can turn to,”; “I have meaningful relationships.” There are a
number of possibilities that may have contributed to the inability of these items to detect
changes. One possibility is that these questions are poor indicators of aspects of consumers’
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lives that are likely to change during treatment. Another possibility is that outside relationships
and living situations are not emphasized enough in the mental health treatment programs in Utah
for there to be measured changes in those areas. A third possibility is that the areas that these
items measure may change more slowly over time than other areas measured by the URS. Yet
another possibility could be that these items cover areas that may change once but not gradually
over time (i.e., once someone has a place to live that they are ok with they are not likely to have
this progress any more). One potential solution to improve the sensitivity to change of the URS
would be to remove these items; however, if the inability of these items to detect changes that are
significantly different from no change is due to a lack of emphasis in these recovery areas in
consumer treatment removing these items would only serve to further take attention away from
these recovery areas deemed important by consumers. Further inquiry is needed to ascertain the
cause of the failure of these items to detect changes.
Validity for Change
In addition to sensitivity to change validity for change was also explored. When HLM
was used to compare consumer treatment trajectories between the two measures the two
measures were found to track change in a similar way. When the two measures were examined
among different classifications of consumers the measures were again found to be mostly
similar. In cases where the slopes of the two measures were significantly different there was no
difference in the directionality of the slopes (positive vs negative) and consistently the URS had
a shallower slope. These observed differences may suggest that the two domains are somewhat
different in terms of the way consumers change throughout treatment. One explanation for the
observed differences between the measures could be that consumer changes in recovery occur
more gradually than consumer changes in distress. For this reason it may be more useful to
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administer recovery instruments like the URS less frequently than distress instruments like the
OQ-45. This approach may also be practically beneficial so-as not to overly burden consumers
with the frequent survey administrations.
In addition, the URS’s ability to detect reliable changes in consumers over time
(Jacobson, Truax, & Kazdin, 1992). The ability of the URS to detect reliable changes was
examined by calculating an RCI for the measure and then comparing this with the established
RCI of the OQ-45. Utilizing the RCI the URS identified 12% of consumers as recovered
(scoring within a range that is most likely to be in a non-clinical population), 77% of consumers
as showing no change, 5% of consumers as improved (moving significantly towards scores that
are likely to fall in a non-clinical population), and 6% of consumers as deteriorated (moving
significantly away from scores that are likely to fall within a non-clinical population).
When compared, the URS identified the proportion of consumers in the same category as
the OQ-45 58% of the time. However, when broken down into individual groups the URS
change categorizations were equal to the OQ-45 to a much lesser extent with the URS
identifying only 42% of the consumers classified as recovered by the OQ-45, 12% of the
consumers classified as improved by the OQ-45, and 23% of the consumers classified as
deteriorated by the OQ-45. In all cases, with the exception of the no change classification, the
URS identified fewer consumers in each category than the OQ-45. This fits with the finding that
recovery as measured by the URS may be less sensitive to clinical changes than distress as
measured by the OQ-45. For this reason, the URS may be most useful as an occasional outcome
measure
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Limitations
One of the major remaining questions regarding the validity of the URS is test-retest
reliability. A high test-retest reliability estimate observed in a group of consumers not receiving
treatment would provide evidence that the URS is actually detecting changes that are the result
of treatment. Further, multiple administrations given to a group of consumers not receiving
treatment could also be compared against consumers receiving treatment to explore whether the
URS as a measure as well as its individual items are sensitive to change over time. Comparing
the URS to a sample of individuals not in treatment would provide further evidence for the
sensitivity of the URS for change because consumers not receiving treatment may show
improvement over time (Aneshensel, Estrada, Hansell, & Clark, 1987; Bromet, Dunn, Connell,
Dew, & Schulberg, 1986; Durham, Burlingame, & Lambert, 1998; Henderson, Byrne, &
Duncan-Jones, 1981; Jorm, Duncan-Jones, & Scott, 1989).
Additionally, consumers were not given the URS at intake. Because of this we were
unable to examine consumer treatment trajectories that started at intake. We were able to look at
consumers beginning treatment in comparison to the OQ-45 but most often these consumers
were not given the URS until their second or third session. Examining a group of consumers that
take the URS at intake and then tracking them throughout treatment might give us not only a
more clear picture of recovery’s longitudinal relationship to distress but also might allow us to
examine time differences between the two (e.g., perhaps a certain level of distress reduction is
required before change in recovery can be observed).
Lastly, it is important to note that the URS was developed utilizing consumer feedback
and focus groups and not from a large pool of items. This is important because it is possible that
utilizing a large pool of items in its construction would have provided a more conservative
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approach to insuring that the domain of recovery was adequately captured. For this reason,
further exploration is needed in comparing the URS with other measures of recovery that are
thought to cover multiple domains of recovery such as the Recovery Assessment Scale (Corrigan
et al., 1999).
Conclusions
Initial evidence for the reliability, validity, sensitivity for change, and validity for change
suggest that the URS may be a useful instrument for clinicians and community mental health
programs that are seeking to measure recovery among consumers over time. Given the results of
the study, the URS appears to be most useful as an occasional evaluative measure of recovery.
The strong inverse relationship observed between recovery and distress is encouraging
for community mental health centers implementing recovery-oriented programs because it
indicates that recovery-oriented interventions are unlikely to detract from and may enhance
treatment efforts that are aimed at reducing consumer symptoms or distress. Further the strength
of the relationship between the two measures may even suggest that recovery-oriented
interventions bolster consumer gains in distress reduction. Since this study was not experimental
further inquiry is needed in order to fully explore the nature of this finding.
In addition, the strong relationship between the OQ-45 quality of life items and the URS
also provide evidence for the potential relationship between recovery and well being. For this
reason, it might be helpful for clinicians to look towards positive psychology research,
particularly in areas of engagement, reported well being, and social relationships as a way of
developing and implementing recovery oriented interventions.
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Table 1
Item Correlations Between the OQ-45 and the URS
URS items
OQ-45 items
1. I have hope for the future. 13. I am a happy person.
15. I feel worthless.
23. I feel hopeless about the
future.
24. I like myself.
31. I am satisfied with my life.
OQ-45 total
2. Most days I get to do
something that I enjoy.
—
3. I do something I enjoy
during the day.
21. I enjoy my spare time.
31. I am satisfied with my life.
OQ-45 total
4. I feel the place I live is ok.
—
5. My life has meaning.
13. I am a happy person.
20. I feel loved and wanted
24. I like myself.
31. I am satisfied with my life.
OQ-45 total
6. I have people/friends that I
can turn to.
20. I feel loved and wanted
7. I am connected to my
community.
—
8. I am in charge of my own
life and recovery.
—
9. I have goals for my future.
—
10. My relationships are
meaningful.
20. I feel loved and wanted
43. I am satisfied with my
relationships with others.
URS total
3. I feel no interest in things.
13. I am a happy person.
20. I feel loved and wanted
21. I enjoy my spare time.
24. I like myself.
42. I feel blue
43. I am satisfied with my
relationships with others.
Note. — indicates that correlations for that item were weaker than .6.

r
-0.634
-0.615

n
8739
8738

-0.671
-0.643
-0.67
-0.67

8746
8742
8761
8750

—

—

-0.65
-0.611
-0.619
—
-0.624
-0.617
-0.638
-0.683
-0.648

8726
8744
8734
—
8714
8731
8716
8736
8724

-0.612

8722

—

—

—
—

—
—

-0.632

8717

-0.617
-0.612
-0.709
-0.702
-0.663
-0.706
-0.608

8705
8474
8483
8491
8483
8487
8495

-0.692

8486
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Table 2
Descriptive Data for the Community and Clinical Samples
Sample
Mean
SD
n
Clinical
19.67
7.072
5,010
Community
35.84
5.455
91
Table 3
Sensitivity and Specificity of the URS Clinical Cutoff Score
Actual
Positive
Negative
(non(consumer)
consumer)
True
False
Positive
Positives
Positives
(consumer)
86
536
Predicted
Negative
False
True
(nonNegatives
Negatives
consumer)
5
4474
91
5010
Total
2%
98%

Sensitivity
0.89

Specificity
0.95

Hit Rate
0.89

Table 4
URS Change Status
Total
Recovered
No change
Improved
Deteriorated

n
1445
176
1114
67
88

% of total
100%
12%
77%
5%
6%

Positive
Predictive
Power
0.99

Total

622
12%
4479
88%
5101
100%
Negative
Predictive
Power
0.14
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Table 5
Consumer change status classified by the URS and the OQ-45.
Total
Recovered
No change
OQ-45
1445
145
815
Matching NRI change status
842
61
699
p of matching status
0.58
0.42
0.86
NRI Recovered
—
—
70
NRI no change
—
65
—
NRI Improved
—
15
21
NRI deteriorated
—
4
25

Improved
251
29
0.12
38
178
—
6

Deteriorated
234
53
0.23
7
172
2
—

Table 6
URS Total and Individual Item Slopes Compared to Zero
Item
Total
1. I have hope for the future.
2. I have meaningful work/volunteer activities in my life.
3. Most days I get to do something that I enjoy.
4. I have a place to live and it's ok.
5. My life has meaning.
6. I have people/friends I can turn to.
7. I am connected to my community
8. I am in charge of my own life and recovery.
9. I have goals for the future.
10. I have meaningful relationships
N = 1954
*p<.05.

Slope
0.07654
0.04967
0.06763
0.07075
0.01913
0.0747
0.02135
0.075
0.07862
0.05082
0.02817

t
5.87*
3.18*
4.03*
4.47*
1.16
5.16*
1.36
4.99*
4.57*
3.48*
0.078
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Table 7
Slope Comparisons by Change Classification Between the URS and the OQ-45
Classification
Slope URS Slope OQ-45
n
t
Total
-0.079204
-0.08045
1954
0.09
Distressed
-0.14791
-0.1921
1151
2.74*
Distressed improved
-0.3765
-0.5247
203
4.07*
Distressed deteriorated
0.37348
0.4402
142
-1.23
Distressed no change
-0.04298
-0.02063
612
-1.19
Distressed recovered
-0.5831
-0.7751
190
4.19*
Not distressed
0.03121
0.09269
798
-2.48*
Not distressed improved
-0.2646
-0.4318
122
2.76*
Not distressed deteriorated
0.7459
0.4733
177
-4.65*
Not distressed no change
-0.03566
0.01192
498
-1.73
Beginning treatment
-0.12559
-.016657
685
1.53
Note. 5 cases could not be classified as distressed or not distressed because they were missing
their initial OQ-45 score and were therefore excluded from subsequent analyses.
5 additional consumers could not have change statuses calculated because of missing data and
were excluded from subsequent analyses.
*p<.05.
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Figure 1: Consumer URS total scores over time compared to zero.
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Figure 2: Consumer OQ-45 and URS total scores over time.
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